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Amblyopia is a neurological condition that affects the visual cortex and causes visual 
deficits, typically in one eye. Recovery from amblyopia requires significant visual cortex 
neuroplasticity to allow for changes in cortical processing.  Non-invasive brain stimulation 
(NIBS) is a technique that can modulate cortical excitability and neurotransmitter 
concentration within superficial regions of the human brain, including the primary visual 
cortex. Recent studies have demonstrated that the application of NIBS to the visual cortex 
can promote neural plasticity and may enable recovery of vision. The overall goal of this 
thesis was to investigate whether repeated sessions of visual cortex NIBS could improve 
vision in adults with amblyopia. To achieve this goal, three specific objectives were pursued: 
(I) Identify the effective transcranial electrical stimulation (tES) protocol for modulating 
visual function in healthy adults, (II) determine whether primary visual cortex transcranial 
random noise stimulation (tRNS) alters cortical excitability in adults with normal vision as 
measured by VEPs, and (III) assess whether repeated primary visual cortex tRNS sessions 
could improve visual acuity and contrast sensitivity in adults with amblyopia.  
Experiment – I  
The purpose of this pilot study was to compare the effects of visual cortex anodal 
transcranial direct current stimulation (a-tDCS), tRNS and sham stimulation on contrast 
sensitivity in healthy adults. The objective was to identify the effective stimulation type for 
experiments II and III. The study also served as an initial pilot of a new NIBS system and 
contrast sensitivity measurement protocol. Within a small sample of healthy adults (n = 6 per 
 
 v 
group), no differences were observed between stimulation conditions. tRNS was chosen for 
subsequent experiments based on trends in the data and the available literature. 
Experiment – II  
We tested the hypothesis that visual cortex tRNS would induce an acute increase in the 
amplitude of pattern-reversal VEPs in healthy adults (n = 10). The purpose of this experiment 
was to test for an electrophysiological effect of tRNS in healthy adults because experiment-I 
had not revealed a psychophysical effect. We found that for measurements made directly 
after active tRNS stimulation, significantly increased VEP amplitudes for parietal electrodes 
relative to sham treatment. Increased VEP amplitudes following tRNS suggest that tRNS acts 
to increase visual cortex excitability. 
Experiment – III  
We tested the hypothesis that five daily sessions of visual cortex transcranial random noise 
stimulation would improve contrast sensitivity, crowded and uncrowded visual acuity in 
adults with amblyopia. Nineteen adults with amblyopia were randomly allocated to active or 
sham tRNS of the visual cortex (active, n = 9; sham, n = 10). Sixteen participants completed 
the study (n = 8 per group). tRNS was delivered for 25 minutes across five consecutive days. 
Monocular contrast sensitivity, uncrowded and crowded visual acuity were measured before, 
during, 5 minutes and 30 minutes post stimulation on each day. Active tRNS significantly 
improved contrast sensitivity and uncrowded visual acuity for both amblyopic and fellow 
eyes whereas sham stimulation had no effect. An analysis of the day-by-day effects revealed 
large within session improvements on day 1 for the active group that waned across 
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subsequent days. No long-lasting (multi-day) improvements were observed for contrast 
sensitivity, however a long-lasting improvement in uncrowded visual acuity in amblyopic 
eyes was observed for the active group. No effect of tRNS was observed for crowded visual 
acuity in amblyopic eyes. In agreement with previous non-invasive brain stimulation studies 
using different techniques, tRNS induced short-term contrast sensitivity improvements in 
adult amblyopic eyes, however, repeated sessions of tRNS did not lead to enhanced or long-
lasting effects for the majority of outcome measures. 
Conclusion 
Our findings buttress the existing reports of improved vision in amblyopia following NIBS of 
the visual cortex. In agreement with previous non-invasive brain stimulation studies, our 
results demonstrated considerable short-term plasticity within the visual cortex of human 
adults with amblyopia. Future research should integrate modification of stimulation 
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Chapter 1: General introduction, aims and objectives 
1.1 General Introduction 
1.1.1 Non-invasive brain stimulation 
Non-invasive brain stimulation (NIBS) techniques enable the modulation of neural activity 
by electrically stimulating targeted brain regions through the scalp. NIBS techniques can 
facilitate neuro-plastic changes and induce after-effects that last beyond the duration of 
stimulation [1,2]. NIBS techniques have been shown to modulate neural excitability in a 
wide variety of brain regions including the motor cortex [3–5], visual cortex [6–10] as well 
as oculomotor areas of the cerebellum [11]. The two main modalities of NIBS are 
transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES). TMS 
can generate action potentials in stimulated neurons. For example, when TMS is applied to 
the motor cortex, it can generate peripheral muscle responses via de-polarization of motor 
neurons [12]. Similarly, stimulation of the visual cortex can induce the perception of 
phosphenes [10]. On the other hand, tES techniques involve the application of a weak 
electrical current to the brain through the skull, using two or more electrodes, and act to alter 
neuronal excitability. tES can be delivered as transcranial direct current stimulation (tDCS), 
alternating current stimulation (tACS) and random noise stimulation (tRNS). The mechanism 
underlying the effects of each tES technique is different [13] [See Chapter 2; and also 
see Paulus et al. 2011 and Antal et al. 2016 for a detailed description of the mechanisms of 
each tES technique]. In brief, tDCS alters cortical excitability through membrane 
polarization, whereby anodal-tDCS depolarizes whereas cathodal hyperpolarizes the resting 
membrane potential [7]. tRNS and tACS induce cortical excitability through interference 
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with ongoing brain oscillations [4,14]. Previous studies have reported that effects induced by 
tES techniques may be due to alterations in the homeostatic balance of neurotransmitters, 
strengthening of functional connectivity of local neuronal networks and promoting the 
expression of brain-derived neurotrophic factor (BDNF) [15–18]. For instance, tDCS was 
found to reduce concentration of the inhibitory neurotransmitter GABA [16] in human [19] 
and animal [16] studies. Previous studies have shown that repetitive transcranial magnetic 
(rTMS) and transcranial electrical (tES) visual cortex stimulation can transiently enhance 
contrast sensitivity and cortical activation in adults with amblyopia [10,20,21]. Recently, 
other studies have also demonstrated that non-invasive tES of the primary visual cortex 
modulates contrast sensitivity in healthy individuals and patients with amblyopia [21,22], 
perhaps by altering the concentration of GABA. These are important findings because 
previous studies in animal models indicated that GABA reduction promoted neural plasticity 
within the visual cortex and recovery of vision in animals with amblyopia [23].  
 
Single and repeated sessions of NIBS have been demonstrated to modulate cognitive 
performance [24–26] and visual function [27–29] in healthy individuals. NIBS has also been 
proposed as a potential tool for the treatment of neurological conditions including stroke, 
depression and amblyopia [20,22,30–32]. NIBS techniques are shown to be safe and 





In a clinical context, amblyopia is defined as reduced visual acuity, despite a healthy eye and visual 
system and best optical correction[37,38] in one or both eyes. Amblyopia in one eye (unilateral 
amblyopia) is diagnosed when there is a 0.2 logMAR difference in visual acuity between the eyes 
measured using an optotype chart, without any pathological disease in the visual system. 
Conventionally, amblyopia can be defined as a neurologically based condition that affects 
visual and extrastriate cortices leading to visual functions deficits in one or both eyes[39,40]. 
Uniocular amblyopia occurs during childhood when both eyes see different images leading to 
abnormal development of the primary and extrastriate visual cortex. The cause of the 
abnormal visual cortex development is suppression of visual inputs from the amblyopic eye 
due to blurred image (anisometropia), visual blockade (deprivation) and/or misalignment 
(strabismus)[41,42]. Individuals with amblyopia suffer from a range of visual deficits 
including deficits of higher-order visual functions[43–47]. Studies assessing the social and 
psychological wellbeing of individuals with amblyopia have reported associated negative 
impacts of amblyopia on quality of life[48–51]. Amblyopia is the second leading causing of 
monocular visual impairment, following cataract, in adults, with a prevalence of 1-
3%[52,53]. The underlying neural mechanism of amblyopia is attributed to an abnormal 
pattern of interocular suppression as well as neural function deficits in the visual 
cortex[39,40,54–59]. The dysfunction in the visual cortex is associated with an imbalance of 
neural excitation and inhibition[39,40,60]. In particular, neural inputs from the amblyopic 
eye elicit weaker neural responses within the visual cortex than inputs from the fellow eye. In 
addition, the strength of interocular suppression is positively associated with the severity of 
the amblyopic eye visual acuity loss[61]. The asymmetrically suppressed intercortical 
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neurons within the visual cortex hemispheres are associated with increased levels of 
GABAergic inhibition[23].  
 
1.1.3 Treatment of Amblyopia 
The efficacy of traditional amblyopia treatments that involve limiting the duration or quality 
of input from the fellow eye vary as a function of age, type of amblyopia and the extent of 
neural suppression. Recent animal models of amblyopia showed that visual cortex 
neuroplasticity still persisted within the adult brain leading to a discovery that a treatment 
regimen can be attempted in human adults with amblyopia[18,62–64]. The mammalian 
visual system has an inborn binocular circuit; hence, the bulk of the cortical neurons are 
binocular. Restoration of visual functions requires binocular stimulation of cortical neurons 
within the visual cortex.  
 
The loss of visual functions following monocular deprivation is associated with decrease of 
visual input driven by imbalance between excitatory and inhibitory cortical neurons. 
Inhibition in the deprived eye dominates the drive of visual input whilst excitation from the 
non-deprived eye is increased. To promote neuroplasticity and restore visual function several 
methods have been attempted. For instance,  the use of tDCS stimulation[65,66], 
pharmacological agents[67–71], environment enrichment[72–74] and visual perceptual 
learning[75–78] have been shown to reactivate ocular dominance plasticity, induce 




In the past 2 decades, the application of non-invasive brain stimulation (NIBS) to a targeted 
area of the human cortex resulted in excitatory or inhibitory effects on binocular cortical 
neurons[7,88]. NIBS aims at modulating binocular cortical function in order to reduce 
interocular suppression. NIBS techniques facilitate neuro-plastic changes yielding enhanced 
neural processing in human visual[7,9,20,22,89–91] and motor cortices[13,88,92–97]. These 
effects last beyond the duration of stimulation. Although NIBS is a new field currently being 
explored extensively, it has gained much attention by demonstrating the possibility of brain 
plasticity in adulthood. Evidence indicates that NIBS enhances the reorganization of 
structural and functional abnormalities of the brain following neurological-based diseases 
such as depression[98–101], post-stoke aphasia[31,102,103] and traumatic brain injury[104–
106]. Recent studies have also reported improvements in contrast sensitivity and visual 
acuity following application of human visual cortex NIBS in adults with amblyopia 
[20,22,107–109]. 
 
1.1.4 Mechanisms of Neuroplasticity 
Neuroplasticity refers to structural and functional changes in the brain that occur in response 
to physiological changes, injuries, new environmental demands and sensory 
experiences[110,111]. Other sources simply define neuroplasticity as the ability of the central 
nervous system to perceive, respond and adapt to extrinsic or intrinsic stimuli[112,113]. The 
mechanism of neural plasticity can be explained at the cellular level of individual neurons 
and at the level of functional networks involving large groups of neurons. Cellular and 
molecular mechanisms that facilitate neuroplasticity include but are not limited to the 
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production of new neurons, growth of axons or dendrites, formation and reorganization of 
synapses and alterations in the speed of synaptic-transmission[112]. For instance, 
mitochondrial biogenesis (the growth and division of mitochondria) and varicosity within an 
individual cell regulate neuroplasticity[114,115]. Also, at the cellular level, neural plasticity 
is facilitated by alteration in the strength of synapses due to patterns of activity within that 
cell or from neighbouring cells connected to it. Activities such as the influx of calcium at the 
synapse regulate the alterations of synaptic strength. For instance, long-term potentiation 
(LTP), an increase in the strength of active synapses and long-term depression (LTD), a 
decrease in the strength of active synapses are activity dependant cellular processes that 
modulate the direction of neural plasticity[116]. Thus, promotion of neuroplasticity is 
dependent on efficiency of synaptic transmission. It has been reported that LTP and LTD are 
dependent on the expression of genes and the synthesis of proteins from a specific cells[117]. 
Among the genes, receptors for neurotrophic growth factors such as brain-derived 
neurotrophic factor (BDNF) regulate neurogenesis, the birth of new neuronal cells, leading to 
the formation of new local network connections. In particular, alterations of BDNF receptor 
gene expression contributes to the mechanisms that modulate synaptic configuration and 
function[112].  
 
In human studies, short-term (~2 hours) monocular deprivation in healthy adults alters 
cortical responses showing that neural plasticity can be induced by temporarily altering 
afferent input to the visual cortex[111]. fMRI and TMS experiments have showed that 
monocular deprivation in healthy adults enhances the visual cortex response to inputs from 
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the recently deprived eye indicating the presence of short-term neuroplasticity[118–120]. For 
instance, Binda et al. used fMRI to demonstrate the neural correlation with BOLD signal 
levels in the visual cortex response to non-deprived and deprived eyes. BOLD responses to 
the high-spatial frequency stimulation of the deprived eye increased and showed the strongest 
cortical activation in V1, V2, V3 and V4. Also, during binocular rivalry performed outside 
the fMRI scanner, they showed that deprivation effects measured by BOLD responses 
correlated with perceptual effects, whereby mean rivalry phase durations were longer/shorter 
after deprivation for the deprived/non-deprived eye, respectively.  
 
1.1.5 Promotion of Neuroplasticity using NIBS 
Monocular deprivation is used to determine visual cortical plasticity. Monocular deprivation 
is created by occluding one eye for a few weeks after birth which causes structural and 
functional changes in the visual cortex. In animal models, monocular amblyopia can be 
induced by monocular deprivation within the critical period (a time of enhanced visual cortex 
neuroplasticity). Monocular deprivation leads to a shift in ocular dominance, structural 
changes (such as atrophy of the lateral geniculate nucleus (LGN) layers) and imbalance 
between inhibitory and excitatory neurotransmitters[121,122]. Earlier studies in amblyopic 
animals demonstrated that infusion of bicuculline or noradrenalin (GABA antagonists) 
significantly restored plasticity and improved visual responses from the deprived eye to the 
occipital cortex[123–125]. Interestingly, these studies showed that curtailing the effects of 
GABAergic inhibitory neurotransmitters restored neuroplasticity within the visual cortex. 
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Therefore, reducing the concentration of GABA within the visual cortex may play an 
essential role to neuroplasticity restoration in animal models[67,126].  
Kasamatsu et al. demonstrated the use of electrical stimulation to restore neuroplasticity in 
monocularly deprived kittens with amblyopia[63]. They built on their previous model that 
electrical stimulation of Noradrenaline(NA)-containing cells in the locus coeruleus (LC) 
released endogenous NA which facilitated and restored neuroplasticity[123,127]. Mature 
animals were kept in the dark and briefly exposed to light with monocular vision (2 hours a 
day for 6 days) combined with 1.5mA LC stimulation. A restoration of visual neuroplasticity 
was observed that persisted for 3 weeks[63]. Their results paved the way for a new 
understanding of neurochemical level effects on neuroplasticity within visual cortex of 
amblyopic animals. Since then researchers have investigated multiple pharmacological 
agents (fluoxetine, acetylcholine, serotonin) to directly reduce intracortical inhibition and 
promote neuroplasticity in post-critical period animals with amblyopia following monocular 
deprivation [67,71,128–130]. However, translating the findings from animal studies of 
neuroplasticity-enhancing pharmacological agents to humans with amblyopia has many 
challenges including a large dosage parameter space and associated side effects[131].   
Recently, researchers have revisited the use of electrical stimulation, as an alternative 
technique to pharmacological agents for regulating the balance between inhibitory and 
excitatory mechanisms to induce visual cortex neuroplasticity plasticity in animals with 
amblyopia. Castaño-Castaño et al. demonstrated that repeated sessions of visual cortex tDCS 
potentially reversed the effects of monocular deprivation on visual acuity and depth 
perception in Long-Evans rats[62,64,132]. The selected animal subjects in each study 
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experienced monocular deprivation for 48 days following monocular occlusion (eyelid 
sutured, and egg white was applied as tissue glue) on postnatal day 12. Prior to tDCS 
stimulation, animals were allowed to recover for 1 month after eyelid opening on day 60. 
They reported a decrease of visual acuity or depth perception in monocular and/or binocular 
viewing conditions following this monocular occlusion during the critical period. tDCS 
(current intensity: 2mA) was delivered for 20 mins per day for 8 consecutive days. The 
amblyopic animals that received the repeated sessions of anodal tDCS showed restored 
plasticity within the visual cortex relative to control animals. The common finding from 
Castaño-Castaño et al. is an acute improvement in visual function following repeated 
sessions of visual cortex tDCS treatment. 
Conclusions from Castaño-Castaño et al. postulated that amblyopia caused by monocular 
deprivation is associated with cortical disorganization that affects visual functioning. Their 
results support the evidence that functional, structural and neurochemical changes are 
dramatically affected in the amblyopic visual cortex following monocular deprivation. 
Finally, their data demonstrated that repeated sessions of tDCS treatment can potentially 
induce balance in ocular dominance and restore neuroplasticity within amblyopic visual 
cortex in animals. 
 
Many studies have demonstrated the use of NIBS to promote neuroplasticity in the human 
brain using neurological based disorders as models[105,133,134]. TMS and tDCS are the 
most widely used NIBS techniques to enhance neuroplasticity in healthy and diseased adult 
brains through alteration of synaptic plasticity and restructuring of local neural 
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networks[133,135]. In healthy adults with amblyopia, the visual cortex was thought to lack 
adequate neuroplasticity[136] for treatment to be beneficial. Recently, reports of visual 
function improvement using NIBS have proven that neuroplasticity still exists in human 
adults with amblyopia. Thompson et al. demonstrated an enhanced contrast sensitivity in the 
amblyopic visual cortex following repetitive transcranial magnetic stimulation (rTMS)[10]. 
Again, NIBS, specifically anodal tDCS delivered to the primary visual cortex, induced 
balancing of cortical activation in response to inputs from the amblyopic and fellow eyes. In 
healthy adult subjects, anodal-tDCS  increased BOLD signal levels in the primary motor 
cortex post stimulation[137], suggesting an increased cortical excitability, synaptic plasticity 
and reconfiguration of intrinsic brain activity networks.  
 
1.2 Specific aims  
1. Identify the most effective transcranial electrical stimulation (tES) protocol for 
modulating visual function in healthy adults. 
2. Determine the effects of primary visual cortex transcranial random noise stimulation 
(tRNS) in adults using VEPs. 
3. Assess the effects of repeated primary visual cortex tRNS sessions on contrast 




1.3 Main objective 
The overall objective of this research was to assess whether tES can be used as a treatment 
modality for amblyopia in adult humans. The first experiment involved piloting of tES 
stimulation protocols and to identify an effective transcranial electrical stimulation protocol 
for modulating contrast sensitivity in humans. We compared the aftereffects of visual cortex 
tDCS, tRNS and Sham stimulation on contrast sensitivity in healthy adults. This pilot study 
did not identify any differences between stimulation conditions. Therefore, tRNS was 
selected for subsequent experiments based on the existing literature. The second experiment 
sought to assess the aftereffects of tRNS using an objective (electrophysiological) method. 
We investigated whether visual cortex tRNS would induce excitability changes as evidenced 
by increased pattern reversal VEP amplitudes post-stimulation in healthy adults. Although a 
similar study had shown that anodal-tDCS transiently and significantly increased visual 
evoked potential (VEP) amplitudes and contrast sensitivity for amblyopic and control eyes 
[22], tRNS effects on VEP amplitudes had not yet been studied. The third experiment 
focused on investigating visual function changes before, during and after visual cortex tRNS 
in healthy adults with amblyopia. The aim was to investigate whether multi-section visual 
cortex tRNS would induce acute and long-lasting improvements in contrast sensitivity and 
visual acuity in adults with amblyopia.  
1.4 Significance of the study 
Amblyopia urgently requires new treatments for adult patients. Available treatments for 
amblyopia are focused on children and teenagers[138], but no treatments are widely available 
for adults. This is due to the (now disproven) idea that the adult brain lacks sufficient neural 
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plasticity to re-learn use of the amblyopic eye. This study expands the evidence base for the 




Chapter 2: Non-invasive brain stimulation (NIBS) as a potential treatment for 
amblyopia: Literature review 
2.1 Introduction  
Amblyopia is a neurological condition that affects the visual cortex leading to visual function 
deficits in one or both eyes [39,40]. Amblyopia is caused by abnormal visual experience 
during childhood that is typically associated with visual deprivation (deprivation amblyopia), 
unequal refractive error between the two eyes (anisometropic amblyopia), ocular 
misalignment that disrupts binocular fusion (Strabismic amblyopia) or a combination of these 
factors[37,41,42]. The presence of one or more of these amblyogenic factors alters visual 
cortex development and, in the case of monocular amblyopia, leads to suppression of inputs 
from the amblyopic eye. Individuals with amblyopia experience a range of visual deficits 
including reduced contrast sensitivity, impaired high-contrast visual acuity, and an absence 
of stereoscopic depth perception [43–47]. In monocular amblyopia, vision deficits are also 
present in the non-amblyopic fellow eye [43]. Supra-threshold deficits such as reduced 
motion sensitivity [47,139], spatial distortions [140–142] and reduced fixational stability 
[143,144] also manifest in amblyopia (both eyes) to different degrees. . Amblyopia is the 
second leading cause of monocular visual impairment in adults with a prevalence of 1-3% 
[52,53]. Many studies that have assessed the social and psychological wellbeing of 
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individuals with amblyopia have observed a negative impact of amblyopia on quality of life 
[48–51].  
 
The conventional treatment for amblyopia in children is occlusion therapy (patching, optical 
penalization and atropine penalization) [139,145] of the non-amblyopic eye combined with 
spectacle correction [146,147] and/or vision therapy [148] in both eyes. If over-administered, 
occlusion therapy may lead to the development of amblyopia in the previously non-affected 
eye [149]. In addition, occlusion therapy is often poorly tolerated by children, especially by 
children with poor visual acuity, increasing the rate of non-compliance and poor treatment 
effectiveness [150]. Regression of treatment effects is also common when occlusion therapy 
is terminated [149]. Other treatment approaches such as dichoptic training [151–157] and the 
use of pharmacological agents [158–161] have been reported to improve visual function in 
amblyopia. However, side effects with pharmacological agents as well as difficulties with 
adherence for dichoptic training represent a challenge to the effective treatment of amblyopia 
in children. Amblyopia treatments are available for children and teenagers, however, adults 
with amblyopia are typically left untreated due to the belief that the mature brain lacks the 
necessary plasticity to enable improvements in visual function [136]. 
 
Recovery from amblyopia requires the presence of neuroplasticity, a property of neural 
systems that decreases with age. The mature human visual cortex was previously assumed to 
lack neuroplasticity [136], however, recent reports have demonstrated that the mechanisms 
that modulate plasticity are retained throughout life [8,60,91,162]. This is supported by 
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studies in animals which demonstrated the presence and restoration of neuroplasticity in 
mature animals following monocular deprivation in infancy [163–165]. For instance, dark 
exposure for several days in mature animals induced significant visual cortex neuroplasticity 
as evidenced by an ocular dominance shift towards the previously deprived eye [163]. 
Additionally, it has been reported that the recovery of neuroplasticity in mature animals is 
associated with the balance of excitation and inhibition within visual cortex [166,167]. Van 
Versendaal et al.[167] showed that monocular deprivation caused an ocular dominance shift 
and a rapid loss of inhibitory synapses in pyramidal neurons within the primary visual cortex 
of kittens, thereby, shifting the bias of cortical responses to the nondeprived eye. Similarly, 
inhibitory synapse loss was associated with increased cortical responses to the deprived eye 
following binocular vision recovery and ocular dominance plasticity [167].  
 
The evidence that neuroplasticity still exists in adulthood has opened up a new research area 
investigating different innovative treatment modalities for amblyopia. Once such modality is 
non-invasive brain stimulation. NIBS can be delivered to a targeted area of the human cortex 
and can modulate neural excitation and inhibition [7,88]. Particular types of NIBS alter the 
homeostatic balance of specific neurotransmitters such as Gamma aminobutyric acid 
(GABA) [168,169] and increase brain-derived neurotrophic factor (BDNF) secretion 
[18,170,171], enhancing neuroplasticity in the human adult brain. Therefore, NIBS may be 
clinically beneficial and is being studied as a potential treatment modality for cortical-based 
conditions such as chronic pain [172,173], tinnitus [97,174], stroke [31,175–180] and 




This review focusses on NIBS experimental studies in subjects with amblyopia. We 
discussed the significance of NIBS as a potential non-invasive treatment regimen aimed at 
improving primary visual functions and restoring neuroplasticity within the visual cortex of 
individuals with amblyopia. We also reviewed the effects of single and repeated sessions of 
visual cortex NIBS on visual cortex function and visual perception in amblyopia. Twelve 
studies published between 2008 and 2020 demonstrated that NIBS has the potential to be 
used as a new treatment regimen for adults with amblyopia Table 1. 
 
Table 1:Summary of non-invasive brain stimulation studies in animal and human 
adults with amblyopia. 
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MD = monocular deprivation; VA = visual acuity; CS = contrast sensitivity; strab = strabismus; aniso = anisometropia; MSO = maximum stimulator output. 
 
2.2 Types of NIBS used in amblyopia studies 
2.2.1 Transcranial magnetic stimulation (TMS) 
TMS (Figure 1) uses an insulated coil of wire placed over the scalp to produce a transitory 
magnetic field which induces an electric current within the underlying cortex. TMS devices 
include a stimulating coil, a capacitor, a resistor and a thyristor switch. These components 
form a RIC (resistor, inductor and capacitor) circuit capable of producing an oscillatory 
sinusoidal (biphasic) current pulse. The stimulating coil also contains a diode which reduces 
coil heating and power utilization. TMS requires a high-voltage (400V– 3kV) and high 
current (4kA-20kA) pulse generator to induce a brief, strong magnetic field perpendicular to 




When the TMS coil is positioned at a targeted area on the scalp, the induced magnetic field is 
attenuated by the external tissues of the head before reaching the neuronal cells. The 
diminished magnetic field is capable of inducing an electric current that is sufficient to 
depolarize the superficial axons and stimulate neuronal systems within the cortex [188].  
 
When applied to the primary motor cortex, single pulses of TMS can cause muscle twitches, 
recorded as motor evoked potentials, that are a result of neural depolarization. The 
mechanisms underlying the effects of TMS on the motor cortex have been explored in detail 
[189,190]. TMS effects are most pronounced for neurons with axons that are parallel to the 
magnetic field.  Non-parallel axons are less likely to be depolarized by TMS pulses. Thus, 
TMS favourably stimulates cortical neurons that are positioned horizontal to the brain 
surface, thereby, when TMS is applied to the primary motor cortex, pyramidal cells and 
axons that connect to the corticospinal tract are most likely to depolarize [12]. For a 
homogeneous system, the direction of induced electrical current and the plane of the TMS 
coil are parallel, and the distribution of current is easy to predict. However, the human brain 
is heterogeneous, and therefore, there is a distortion of the distribution of induced electrical 
current within the intracranial tissue. This means that the prediction of the distribution of the 
electrical current requires extensive modelling with internal and external factors considered.  
For example, Roth et al.[191] used numerical computation to show that the magnitude of the 
electric field generated by TMS is a function of the position, shape and orientation of the 
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magnetic coil. Barker et al.[3] recognized that the depth of cortical neurons or peripheral 
nerve cells also determines the probability that the cells will be depolarized by TMS.  
 
 
Figure 1: Transcranial magnetic stimulation is being demonstrated by researchers from 
the University of Waterloo. 
 
Transcranial magnetic stimulation can be applied to both the central nervous system and 
peripheral nerves. Baker et al.[3] were the first to introduce the application of painless non-
invasive TMS to the human motor cortex, and showed that a single TMS pulse  induced 
movement in muscles that received impulses from the corticomotor neurons under the site of 
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stimulation. They then suggested that TMS function and efficacy should be tested in 
neurological conditions. Since then the use of TMS has evolved to include the evaluation of 
inhibitory or excitatory neuronal populations [190,192], the study of neuroplasticity 
mechanisms [190,193,194] and the exploration of treatments options for  a wide range of 
neurological conditions [30,179,195–197]. TMS is also used to study the relationship 
between specific brain areas, behavioral performance and perception [11,24,198].  
 
2.2.1.1 Repetitive Transcranial magnetic stimulation (rTMS) 
rTMS refers to the application of recurring TMS pulses to a targeted brain area. Rapidly 
repeated TMS pulses induce changes in cortical excitability, possibly by changing the 
strength of synaptic connections in a manner similar to long-term depression (LTD) or long-
term potentiation (LTP) [96,192]. The direction of the change in cortical excitability induced 
by rTMS depends on the frequency, intensity of stimulation and coil orientation. Rossi et 
al.[199] and Machii et al.[36] reported stimulation frequency ranges that are safe for the 
human brain, and further established that low frequencies (below 1-5 Hz) induced inhibitory 
(LTD) whereas higher frequencies ( 5 Hz and higher) induced excitatory (LTP) effects when 
applied to the motor cortex [199]. In addition to the motor cortex, the efficacy of rTMS has 
been extensively studied in a number of human brain areas especially in the parietal [200–
202], visual [10,203,204] and extrastriate [205–207] cortices. There is initial evidence 
suggesting that rTMS can be used as a potential treatment option for neurological conditions 
(stroke-rehabilitation, migraine, Alzheimer's disease, multiple sclerosis, traumatic brain 
injury and schizophrenia) [32,96,105,106,179–181,187,208,209] and psychiatric disorders 
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(obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder) [188] 
[see Lefaucheur 2014 for a detailed review].  
 
rTMS applied over primary visual cortex of adults with amblyopia has been shown to induce 
improvements in visual function, providing evidence for a restoration of neuroplasticity. 
Thompson et al.[10] were the first to investigate the effects of single sessions of visual cortex 
rTMS in adult humans with amblyopia. Low-frequency 1 Hz stimulation was performed on 9 
subjects with amblyopia and 6 out of the 9 subjects with amblyopia were also tested with 
higher-frequency 10 Hz stimulation. Contrast sensitivity for low-spatial-frequency and high-
spatial-frequency gratings was measured directly before, directly after, and 30 min after 
occipital rTMS. The effects of 10 Hz visual cortex rTMS on contrast sensitivity was also 
tested for a control group of 5 subjects with normal vision. For high and low spatial 
frequency viewing conditions, the study demonstrated that 1 Hz visual-cortex stimulation had 
no effect on contrast sensitivity for the amblyopic grouped data. However, considering only 
responders to rTMS treatment (7 out of the 9 subjects), there were significant effects of 
rTMS at post 30mins for high spatial frequency contrast sensitivity. All amblyopic subjects 
who received 10 Hz stimulation showed a significant improvement in high spatial frequency 
contrast sensitivity of the dominant eye immediately and 30mins after stimulation. 
Additionally, control data showed that 1Hz motor cortex rTMS had no reliable effects on 
contrast sensitivity for the subjects with amblyopia. In subjects with normal vision, 10 Hz 
rTMS over the visual cortex induced a significant improvement in contrast sensitivity 
immediately after stimulation. Comparing the relative effects induced by 1 Hz and 10 Hz 
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visual cortex rTMS in adults with amblyopia, 10 Hz showed enhanced contrast detection for 
high spatial frequencies for the group as a whole whereas 1 Hz showed improved contrast 
detection only for a subset of participants. This suggested that 10Hz may be effective 
stimulation protocol. In agreement with motor cortex rTMS studies [32,199], visual cortex 
rTMS has the possibility of inducing neuroplasticity. There are a few limitations that make it 
difficult to extrapolate the results from this study: first, the sample size was small which may 
have impeded reliable results from the group data due to insufficient statistical power; and 
second, the sample size was too small to assess whether the rTMS effect varied across 
amblyopia subtypes. Other limitations that the authors recognized were that other types of 
visual functions as well as multiple sessions of rTMS were not assessed.  
2.2.1.2 Theta burst stimulation (TBS) 
More recently, another rTMS technique called theta burst stimulation (TBS), has been 
introduced [210,211]. TBS uses a lower stimulation intensity and a shorter duration of 
stimulation which have be shown to produce robust and long-lasting effects on cortical 
excitability. However, the main advantage of TBS is the speed of application, whereby TBS 
takes a maximum of 2-3 mins while 1 Hz rTMS takes 20-30mins. Aftereffects of both 
standard rTMS and TBS on cortical neurons have been demonstrated using electrophysiology 
[212–214] and functional magnetic resonance imaging (fMRI) studies [215–218]. TBS 
stimulation protocols are based on in vitro studies of hippocampus cells indicating that bursts 
of rapid electrical stimulation repeated at 5-10 Hz can induce long-term potentiation (LTP) 
and promote neuroplasticity [219]. TBS be can be delivered as continuous (cTBS) or 
intermittent (iTBS) pulse sequences. cTBS and iTBS have opposite effects on cortical 
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excitability when applied to the motor cortex. cTBS induces cortical inhibition whereas iTBS 
induces excitation. Specifically, in the first demonstration of cTBS, Huang et al.[210] 
reported decreased MEP amplitude (inhibition) after motor cortex cTBS and increased MEP 
amplitude (facilitation) after motor cortex iTBS. The effects lasted for more than 20 mins.  
They also reported that the duration of the stimulation aftereffects was affected by the 
number of TMS pulses applied. Their study showed that 40 sec of cTBS with a total of 600 
TMS pulses (i.e., 40 s cTBS) decreased MEPs for 60 min, whereas 300 TMS pulses 
decreased MEPs for only 20 min. Subsequent studies have reported enhanced motor learning 
in healthy subjects following motor cortex TBS [211,220,221]. 
 
With regard to amblyopia, Clavagnier et al.[20] applied five repeated daily sessions of cTBS 
over the primary visual cortex, and assessed both acute and long-lasting effects on contrast 
sensitivity in adults with amblyopia.  Subjects viewed high contrast stimuli with the non-
amblyopic eye while visual cortex cTBS was delivered. The rationale for this was that 
neurons responding preferentially to the fellow eye would be active during stimulation and 
therefore be more affected by the inhibitory effects of cTBS. Preferential inhibition of 
neurons responding to the fellow eye would, in turn, reduce suppression of the neurons 
driven by the amblyopic eye. Contrast sensitivity for a range of spatial frequencies (0.5, 1, 2, 
5 and 10 cpd) was measured before, directly after, and 30 min after cTBS. The cTBS 
protocol consisted of 600 pulses per session which were delivered as bursts of three 50 Hz 
pulses for 200 ms over a 40 s stimulation duration. Both single and repeated sessions of 
cTBS were delivered to 5 and 4 subjects respectively, whereas 3 out of the 5 subjects 
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participated in follow-up visits after the last stimulation session. Significant improvements 
from baseline in amblyopic eye contrast sensitivity were observed for high spatial 
frequencies on days 1-3 and there was a cumulative improvement in baseline contrast 
sensitivity from one day to the next. The cTBS-induced improvements on contrast sensitivity 
were sustained 8, 19 and 78 days after the final stimulation session in three participants who 
were available for follow-up testing.  
 
The major limitation of this study is the small sample size and lack of assessment of cTBS 
effects on different visual functions, however, the data demonstrate that the use of cTBS as a 
treatment regimen in adults with amblyopia is potentially promising. In agreement with 
previous studies [10], rTMS and cTBS enhanced high spatial frequency contrast sensitivity in 
the amblyopic eye of adults with amblyopia. Thus, cTBS results replicated the single session 
1 Hz rTMS results from Thompson et al.[10].  
 
Recently, Tuna et at.[222] explored the effects of cTBS on visual acuity, suppressive 
imbalance (related to interocular suppression), and stereoacuity in adults with amblyopia. 
Their cTBS protocol involved 600 pulses continuously delivered in bursts of 3 pulses at 50 
Hz and repeated at 5-Hz for 40 sec. A single session of cTBS was applied at a location on the 
occipital cortex where phosphenes were induced in 13 subjects with amblyopia (8 subjects 
received active cTBS treatment whilst 5 received sham cTBS treatment). The results showed 
reliable improvements in visual acuity, stereoacuity and suppressive imbalance in the active 
cTBS treatment group relative to the sham group although there was considerable inter-
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individual variability. This study provides further evidence that neuroplasticity can be 
restored in the visual cortex of adults with amblyopia following application of cTBS.  
 
Possible mechanisms for improved vision in amblyopia following visual cortex rTMS or 
cTBS include a balancing of the cortical response to input from each eye. Under normal 
circumstances, the visual cortex response to stimulation of the fellow eye is much larger than 
the response to stimulation of the amblyopic eye [21,223–227]. Because the effects of rTMS 
and cTBS are state- dependent [228,229], they may act to preferentially increase excitability 
of the less active amblyopic eye dedicated cells or reduce excitability of the fellow eye 
dedicated cells therefore allowing a more balanced cortical responses to input from each eye. 
In addition, rTMS and cTBS may alter cortical inhibition which is key factor in the 
regulation of visual cortex neuroplasticity [23,230,231].  
2.2.2 Transcranial electrical stimulation (TES) 
Brain alterations in adult humans induced by small polarizing currents were described in 
1964 by Lippold and Redfearn [232,233]. Subsequent studies showed long-lasting 
therapeutic effects of brain polarization in neurological and psychiatric disorders [233] such 
as depression [234,235]. For example, Costain et al.[236] reported that brain stimulation 
using a weak direct current (100-250A) improved the symptoms of depression. In earlier 
animal work, Bindman et al.[237] reported excitatory after-effects of surface-positive cortical 
polarization in rats. Later, the effects of electrical stimulation applied to the locus coeruleus 
(LC) were assessed within the parietal cortex in vitro by Semenyutin et al.[238]. The results 
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showed that the stimulation caused neural hyperpolarization and an inhibition of background 
activity.  
 
Following this earlier work, the application of tES to the human brain was revisited by 
Nitsche and Paulus (2000) who applied a weak electrical current to the scalp through a pair 
of surface electrodes (Figure 2). The electric current generated an electric field that caused 
modification of membrane polarization resulting in cerebral excitation or inhibition 
depending on the current polarity (anodal vs. cathodal stimulation). They showed that the 
aftereffects of tES lasted longer than the stimulation duration by varying the current intensity 
and duration [88]. The changes in cortical excitability were explained in the context of LTP 
and LTD-like mechanisms that altered synaptic strength [239]. Further investigations have 
reported other underlying mechanisms of tES effects such as alterations in the concentration 
of the inhibitory neurotransmitter GABA [15,168,169], BDNF secretion, Tropomyosin 
receptor kinase B (TrkB) activation within the cortex [18,170] and changes in regional 
neuronal activity [240,241].  
  
tES can be delivered as transcranial direct current stimulation (tDCS), transcranial random 





Figure 2: tES apparatus. Two surface electrodes (red: active electrode; blue: reference 
electrode) placed on the scalp with the reference electrode at CZ and the active 
electrode at either midline (left panel) or lateral occipital cortex (right panel). 
 
2.2.2.1 Transcranial direct current stimulation (tDCS) 
tDCS is a non-invasive brain stimulation technique that applies a mild (1-2 mA) [7,88] direct 
electrical current through the scalp to modulate neuronal excitability. Antal et al., 2001;2004 
demonstrated anodal (a-tDCS) and cathodal (c-tDCS) direct stimulation over the motor 
cortex enhanced or reduced cerebral excitability in healthy humans [7,9]. The effects of 
tDCS are potentially promising for neuroplasticity. tDCS studies have reported 
improvements in patients suffering from neurological-based disorders including stroke [176–
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179], chronic pain [172] and tinnitus [174], and tDCS can be considered as a tool for 
activating the processes of cortical reorganization and functional neurorehabilitation 
[60,185,208].  
 
Long-lasting effects of tDCS can be achieved when tDCS is combined with peripheral 
stimulation methods.  Hesse, 2007 and Nair, 2011 showed that the combination of motor 
cortex  a-tDCS and peripheral nerve stimulation increased synaptic plasticity and potentiated 
the relearning of motor skills [242,243]. a-tDCS has also been combined with perceptual 
learning and virtual reality therapy [244] to assess whether the stimulation can augment other 
treatment approaches. The mechanism of enhanced synaptic plasticity following augmented 
treatments may be due to the fact that a-tDCS effects enhance brain excitability whereas 
peripheral therapy alters LTP/LTD trans-synaptic strength [245].  
 
There is a growing body of evidence indicating that visual cortex neuroplasticity can be 
restored by reducing cortical inhibition [10,23,61,125,151]. Spiegel et al.[21] investigated 
whether a single session of visual cortex a-tDCS (2mA; 15minutes) would reduce inhibition, 
facilitate cortical excitability and enhance contrast sensitivity in adult patients with 
amblyopia. To determine the effects of a-tDCS on cortical responses to visual inputs from 
amblyopic and fellow eyes, fMRI measures of the BOLD signal level were compared 
between a-tDCS and s-tDCS for each visual area (V1, V2, V3, V3a, and V4). Contrast 
sensitivity was assessed before, during, immediately after and 30 mins after a-tDCS or c-
tDCS in 13 adult subjects with amblyopia, and 5 out of the 13 subjects who responded to a-
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tDCS treatment participated in the fMRI investigation. Considering the whole data set, the 
study reported no reliable improvement in contrast sensitivity in the amblyopic eye following 
either a-tDCS or c-tDCS. However, c-tDCS significantly improved contrast sensitivity in the 
fellow eye immediately after stimulation. A cluster of “responders” (N = 8) showed a 
significant improvement in amblyopic eye contrast sensitivity immediately after and 30 
minutes post a-tDCS. The fact that the effects of visual cortex tDCS on visual function were 
not observed in all subjects is in agreement with other studies that reported inter-individual 
variability of tDCS effects in the human brain [246–248]. A larger sample size and clustering 
of subjects into amblyopia subtypes may have enabled the observation of greater tDCS 
effects.  
 
fMRI measures were obtained from a subset of responders to assess whether tDCS induced 
any measurable cortical changes that could explain the contrast sensitivity improvements. 
When sham (placebo) tDCS was applied to the visual cortex, fMRI measurements showed 
asymmetrical activation within visual cortex areas whereby significantly higher activation 
was observed for visual stimulation of the fellow eye. This bias in visual cortex activity 
towards the fellow eye was significantly reduced by visual cortex a-tDCS.  Balancing of the 
cortical response to each eye, possibly due to reduced cortical inhibition, may underlie the 
amblyopic eye vision improvements that can be induced by a-tDCS. 
 
Building on the study conducted by Spiegel et al.[21], Ding et al.[22] explored the effect of 
visual cortex a-tDCS in older teens and adults with amblyopia using monocular pattern 
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reversal visual evoked potentials (VEPs) and psychophysical measures of contrast sensitivity. 
An amblyopia group (n = 21) and a control group (n = 27) completed six study sessions, 
three involving VEP measures and three involving psychophysical measures. For each 
measure, participants completed one real a-tDCS session (2mA; 20minutes), one cathodal 
tDCS condition and one sham tDCS condition. VEP recordings and contrast sensitivity 
measurements were made for amblyopic and fellow eyes, but only one randomly selected eye 
for the control subjects. They reported an increased VEP amplitude for amblyopic, non-
amblyopic and control eyes directly after and 30 minutes post a-tDCS. As expected, c-tDCS 
reduced the VEP amplitudes and sham stimulation had no effect. Anodal and cathodal tDCS 
effects did not affect peak latencies. For contrast sensitivity, there was a reliable and transient 
contrast sensitivity improvement following a-tDCS whereas c-tDCS had the opposite effect. 
Further VEP baseline measurements were carried to investigate long-lasting a-tDCS effects, 
and the results showed a reliable increase in VEP amplitudes 48 hours after the last a-tDCS 
session. Sham stimulation had no effect for any condition.  
 
Together, the results from Spiegel et al. [21] and Ding et al.[22] demonstrate that a single 
session of a-tDCS can transiently enhance contrast sensitivity in the amblyopic eyes of adult 
patients. The effects of a-tDCS on cortical activation also suggest that that the underlying 
mechanism of a-tDCS effects involves a reduction of cortical inhibition within the visual 
cortex. The cumulative effects of tDCS over several days, if any, should further be 




Recent reports on amblyopia treatment have suggested that enhancement of visual functions 
in adults with amblyopia can be achieved by reducing suppression of visual inputs from the 
amblyopic eye using dichoptic video games [151,154,157,249,250]. Spiegel et al.[89] 
investigated whether visual cortex a-tDCS (2mA; 15minutes) could augment the effects 
dichoptic video play game on stereopsis and amblyopic eye visual acuity in adults with 
amblyopia. Within the study, sixteen adults with amblyopia (5 out of 16 subjects had 
previous patching treatment) participated in a crossover-design intervention. The participants 
were split into two equal groups. A-tDCS of the visual cortex was delivered to group 1 
during the first 5 dichoptic training sessions whereas s-tDCS of the motor cortex was given 
to the same group during the second 5 dichoptic training sessions. The order of tDCS 
conditions was reversed for group 2. The study reported greater and long-lasting 
improvements in stereopsis in both groups when a-tDCS was combined with dichoptic 
treatment relative to dichoptic treatment administered alone. However, although long-lasting 
improvements in amblyopic eye visual acuity were observed in both groups, there was no 
additional effect of a-tDCS.  This suggests that the augmenting effect of a-tDCS on dichoptic 
treatment may be specific for binocular visual functions. The dichoptic treatment was 
designed to reduce suppression of the amblyopic eye by exposing the visual system to stimuli 
that could be binocularly combined [151,155], whereas a-tDCS was hypothesized to reduce 
GABA mediated inhibition, thereby reducing suppression of the amblyopic eye 
[15,21,22,168]. The study results suggested that these two approaches are additive, thereby 




Neural interactions within visuo-cortical areas in the two hemispheres are facilitated by fibers 
that pass through the corpus callosum [251,252]. In animal studies, it has been reported that 
callosal connections are responsible for suppression of the amblyopic eye following early 
monocular deprivation [253,254]. Therefore, dampening the effects of callosal 
interhemispheric inhibition may decrease the level of interocular suppression and potentially 
enhance cortical responses and improve visual function in amblyopia. In agreement with this 
hypothesis, there is initial evidence that the corpus callosum may modulate both inhibition 
and excitation of the contralateral hemisphere [251,255,256]. Bocci et al.[90] investigated the 
effects of visual cortex c-tDCS (1.5mA; 20mins) on interhemispheric cortical responses and 
visual function changes in adults with amblyopia. Cathodal tDCS was applied over the 
occipital cortex contralateral to the amblyopic eye, and visual acuity and VEP amplitudes 
(induced by 90% and 20% contrast grating stimuli) were measured. The results showed a 
reliable improvement in amblyopic eye visual acuity following c-tDCS, and the aftereffects 
lasted for about 1 hour. Sham stimulation had no effect. Therefore, the results indeed 
demonstrated that the cortical inhibitory effects induced by c-TDCS have the potential to be 
used as a treatment for amblyopia in human adults.  
 
Regarding the VEP results reported by Bocci et al., at both low and high-contrasts, VEP 
amplitudes increased post c-tDCS for the occipital hemisphere ipsilateral to the amblyopic 
eye relative to control subjects with normal vision. The effects lasted for up to 1 hour. In 
contrast, a reduction of VEP amplitude was observed immediately after c-tDCS, for high and 
low-contrasts, at the occipital hemisphere contralateral to the amblyopic eye (the hemisphere 
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that received c-tDCS). The authors propose that this pattern of VEP amplitude change 
indicates a reduction of interhemispheric inhibitory effects within the visual cortex.   
 
In agreement with studies in humans, recent animal studies [62,64,132] showed that tDCS 
has the potential to enhance visual functions in adult amblyopia. Castaño-Castaño et 
al.[62,64,132] demonstrated that repeated sessions of visual cortex a-tDCS reversed the 
effects of early monocular deprivation on visual acuity and depth perception in Long-Evans 
rats. Across three separate studies, the animals experienced monocular deprivation for 48 
days following monocular occlusion (eyelid suture, and egg white was applied as tissue glue) 
on postnatal day 12. Prior to tDCS stimulation, animals were allowed to recover for 1 month 
after eyelid opening on day 60. The monocular deprivation induced dense monocular 
deprivation amblyopia associated with impaired monocular and binocular visual acuity along 
with absent stereoscopic depth perception. tDCS (2mA) was delivered to the visual cortex 
contralateral to the amblyopic eye for 20 mins per day for 8 consecutive days. Amblyopic 
animals that received repeated sessions of anodal tDCS experienced restoration of plasticity 
within the visual cortex relative to control animals. 
 
Prior to a-tDCS, two of the studies reported decreased parvalbumin (PV)-positive cells and 
Glucose (18F-FDG) uptake within the visual cortex following monocular deprivation 
respectively [64,132]. Parvalbumin cells are calcium-binding proteins present in some 
GABAergic interneurons in the cortex. Functionally, parvalbumin is involved in a variety of 
physiological processes including cell-cycle regulation, second messenger production, 
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muscle contraction, microtubule organization and vision [257]. Therefore, an increase in PV-
positive cells may contribute to functional organization and restoration of neuroplasticity 
within the visual cortex. Indeed, the effects of repeated sessions of tDCS resulted in an 
increased and balanced PV-positive cell level within the visual cortex areas. Similarly, 
following repeated a-tDCS there was balanced cortical activation within the visual cortex 
areas. Previous studies have also used 18F-FDG to evaluate cortical activations in the brain 
especially in neurological diseases [258,259] including amblyopia [223,224,226]. 
 
Overall, the results of the rat studies conducted by Castaño-Castaño et al. indicate that 
repeated sessions of daily tDCS over the primary visual cortex induce a period of 
neuroplasticity that enables a restoration of ocular dominance balance in amblyopic animals. 
However, the authors observed the following study limitations: (i) visual function 
progression following each day’s tDCS treatment was not tested, and (ii) sustained long-term 
tDCS aftereffects were not assessed.  
2.2.2.2 Transcranial random noise stimulation (tRNS) 
tRNS modulates cortical excitability by interfering with the continuing neural oscillations in 
the brain through the delivery of an electrical current with a randomly oscillating frequency 
and amplitude [4,260]. tRNS induced greater and reliable effects when compared with tDCS 
and tACS [13,97,261] [See Paulus, 2011; for detail description of each stimulation method]. 
For instance, in healthy individuals, Inukai et al.[261] showed that motor cortex tRNS 
induced the largest significant increase in MEPs relative to sham stimulation of the various 
stimulation types tested. Similarly, Vanneste et al.[97] reported a larger transient suppressive 
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effect on the tinnitus loudness and tinnitus related distress when tRNS was applied over the 
auditory cortex of tinnitus patients compared to other stimulation protocols. 
 
Within tRNS protocols, the spectrum of different of frequencies can either cause a reduction 
or enhancement of motor cortex excitability [4,262]. Thus, effect of low- frequency tRNS (lf-
tRNS; 0.1–100 Hz) induced no or reduced cortical excitability whilst high-frequency tRNS 
(hf-tRNS; 100–640 Hz) induced an opposite effect [4,108,263]. However, Fertonani et al.[91] 
reported that the effects of visual cortex tRNS on visual perceptual learning enhancement 
showed no statistically significant difference between the effect of high frequency (101-640 
Hz) and low frequency (0.1-100 Hz) tRNS. 
 
Following the previous work of Spiegel et al.[89] showing that combined perceptual learning 
and a-tDCS treatment enhanced visual function in adults with amblyopia, Moret et al.[108] 
adopted the same principle and combined high-frequency transcranial random noise 
stimulation (hf-tRNS) with a short perceptual training, and reported an improvement in 
visual function in adults with amblyopia. They administered visual cortex hf-tRNS (1.5mA; 
25mins) during 8 perceptual training sessions in 10 adult subjects with amblyopia, and 
compared the results to a sham stimulation group. Both groups received 8 sessions of 
monocular perceptual training using the amblyopic eye during which subjects performed a 
contrast detection task by detecting the presence of a central Gabor patch flanked by two 
high-contrast collinear Gabor patches. Hf-tRNS was delivered within the first 5 blocks of 
each training session. Contrast sensitivity (measured with different spatial frequencies; 0.8, 
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2.9, 5.8, 9.7 and 14.5 cpd) and visual acuity were assessed before and after monocular 
perceptual training with or without visual cortex hf-tRNS. The study reported, for all the 
spatial frequencies tested, that perceptual training alone enhanced contrast sensitivity in the 
amblyopic/trained eye and non-amblyopic/untrained eye for both the active and sham tRNS 
groups.  The effect of perceptual learning on contrast sensitivity was not reliably improved 
by hf-tRNS, however, the magnitude of improvement in both the trained and untrained eyes 
was larger in the hf-tRNS group. Similarly, for both trained and untrained eyes, there was a 
significant enhancement of visual acuity in the hf-tRNS group only. The results of this study 
are consistent with the authors’ previous pilot study [264] in which visual acuity and contrast 
sensitivity improved following visual cortex hf-tRNS (1.5mA, 25mins) combined with short 
perceptual training in adults with amblyopia (N = 7). It remains to be seen whether the 
effects of combined perceptual learning and NIBS are long lasting in adults with amblyopia 
and whether the effects can be replicated in larger samples within randomized clinical trial 
designs.  
 
To investigate acute and long-lasting effects of tRNS, we [see experiment 3] tested whether 
five daily sessions of visual cortex tRNS (2mA; 25 minutes) would improve contrast 
sensitivity, crowded and uncrowded visual acuity in adults with amblyopia. the effects of 
active or sham tRNS of the visual cortex was assessed in 16 adults with amblyopia (active, n 
= 8; sham, n = 8). Visual function outcomes were measured before, during, 5 minutes and 30 
minutes post stimulation on each day, and baselines were again measured on day 28 after the 
last day of stimulation. The results showed that repeated sessions of visual cortex tRNS 
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induced an acute improvement of visual functions in adult patients with amblyopia. 
Specifically, tRNS improved contrast sensitivity and uncrowded visual acuity relative to the 
sham group for both amblyopic and fellow eyes. tRNS improved crowded visual acuity in the 
fellow but not the amblyopic eyes. However, we did not find successive and cumulative 
tRNS effects on all visual function outcomes. Therefore, repeated sessions of tRNS using the 
same stimulation parameters for each day, may not induce long-lasting tRNS effects on 
visual function in amblyopia. It is possible that increasing the sample size and changing 
stimulation parameters for each day may elicit greater reliable long-lasting tRNS effects [See 
Chapter five for more details about experimental procedure]. 
2.3 General summary 
All the recent animal studies discussed in this review investigated the effects of repeated 
sessions of visual cortex tDCS with the aim of restoring neuroplasticity in monocularly 
deprived amblyopic rats. Using the same stimulation protocol, visual cortex tDCS 
significantly improved visual acuity and depth perception. Similarly, tDCS application 
boosted physiological processes and enhanced symmetric cortical responses between 
occipital hemispheres within the visual cortex of the animals. In human studies, there was a 
reliable improvement in visual functions in adults with amblyopia following single or 
repeated sessions of visual cortex TMS. In particular, the effects of cTBS reliably improved 
visual acuity, suppressive imbalance, and stereoacuity. With regards to visual cortex tES, a-
tDCS and/or c-tDCS induced enhancement of contrast sensitivity and visual acuity. Direct 
neurophysiological and electrophysiological measurements (fMRI and VEP) demonstrated 
that tDCS enhanced cortical responses to inputs from the amblyopic eye, and balanced 
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cortical activation in response to inputs from the amblyopic and fellow eyes. Lastly, both 
tDCS and tRNS have been found to enhance the effects of perceptual learning on visual 
function in adults with amblyopia. Whether repeated sessions of NIBS alone (i.e., in the 
absence of perceptual learning) can lead to cumulative effects remains uncertain. Initial 
evidence for cumulative effects of visual cortex cTBS were reported by Clavagnier et al.[20]. 
 
We observed some study limitations with the papers reviewed. Most studies had a small 
sample size, which may have reduced statistical power and masked any subtle effects of 
NIBS. Almost all studies did not perform a cluster analysis for subtypes of amblyopia among 
the selected cohort. Whether the effects of NIBS vary depending on amblyopia subtype is an 
important clinical question related to the potential use of NIBS for amblyopia treatment.  
Also, the effects of TMS and tES were mostly tested on one visual function for the majority 
of studies. Each visual function is processed differently within the visual cortex and, 
therefore, testing other functions may have revealed greater or more reliable effects. Lack of 
repeated sessions and assessment of long-lasting effects of NIBS were observed in most of 
the human studies. Lastly, none of the studies were conducted using randomized control trial 
(RCT) methodology to reduce various forms of bias, and to provide a rigorous measure of the 
effectiveness of NIBS for the treatment of amblyopia in human adults.  
2.4 Conclusion and outstanding research questions 
Transcranial magnetic and electrical stimulation studies have demonstrated remarkable 
improvements in visual functions and restored neuroplasticity in adult humans and animals 
with amblyopia. Both single and repeated sessions of TMS or tES can be used to induce 
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neuroplastic effects within the visual cortex of amblyopic adults. Finally, tES augmentation 
with perceptual learning can be a potential treatment option for adults with amblyopia. Many 
areas recognized as weaknesses in previous studies need to be explored regarding the effects 
of visual cortex TMS and tES in healthy adults with or without amblyopia. The most 
effective form of tES for inducing visual cortex neuroplasticity requires further investigation. 
In addition, direct objective assessment of the effects of visual cortex tES in humans needs 
further investigation. This is because the majority of studies focussing on tES mechanisms 
focus exclusively on the motor cortex and it is unknown whether the results of these studies 
also apply to the visual cortex. A deeper understanding of tES mechanisms will enable the 
development of more effective tES protocols for amblyopia treatment. Additionally, 
cumulative and long-lasting effects of visual cortex tES in humans should be investigated. 
This issue is critical for the clinical use of tES for amblyopia treatment. The experiments 
reported in this thesis were designed to address these questions. Specifically, a pilot study 
was conducted to investigate the application of visual cortex tRNS in healthy adults and 
assess its effects on contrast sensitivity as compared with a-tDCS and sham stimulation. A 
larger experiment was then conducted to objectively assess the effect of tRNS on visual 
cortex excitability using EEG in participants with normal vision. Finally, an experiment was 
conducted to investigate the effects of repeated visual cortex tRNS, over several days, on 





Chapter 3: Identification of the effective transcranial electrical stimulation 
technique for modulating contrast sensitivity in humans: a pilot study 
3.1 Introduction 
The three tES methods ( tDCS, tRNS and tACS) have the capability to induce cortical 
excitability and enhance neuroplasticity in the human brain [4,13,208]. tDCS induces cortical 
excitability through membrane polarization, whereby anodal-tDCS depolarizes whereas 
cathodal-tDCS hyperpolarizes the resting membrane potential. tRNS and tACS induce 
cortical excitability through interference with ongoing brain oscillations. The after-effects 
induced by each tES method vary and maybe dependent on factors such as the stimulation 
parameters used and inter and intra-individual variability [88,247,248]. It is important to find 
the most reliable tES technique for inducing cortical plasticity before conducting treatment 
studies for individuals with neurological disorders. Currently, only a few studies have 
compared the efficacy of tES methods using the same stimulation parameters in the same 
cohort of subjects[97,261,262]. All the three studies reported that tRNS was the most 
effective tES method for modulating cortical function. For instance, Vanneste et al.[97] and 
Moliadze et al.[262] applied 1 mA of a-tDCS, full spectrum tRNS and tACS over primary 
motor cortex for 10 minutes. MEP amplitudes increased post stimulation showing an increase 
in cortical excitability. Among the stimulation methods, tRNS induced the greatest effect on 
MEPs, however, Moliadze et al. reported that a-tDCS reliably produced the longest MEP 
increase compared to sham stimulation. Different studies have applied different tES methods 
(non-comparative studies) over the primary visual cortex to modulate phosphene threshold 
and visual function in normally sighted individuals and to improve vision in brain based 
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vision disorders such as amblyopia[9,21,22,90,109,265–267]. However, at present, there are 
no studies comparing tES methods when applied over the visual cortex using the same 
stimulation parameters and visual function outcome measures.  
 
The major aim of this pilot study was to identify the effective tES protocol (tDCS or tRNS) 
for modulating visual function (contrast sensitivity) in healthy adults while applying 2mA 
current to the visual cortex for 15 mins. We hypothesized that a single session of visual 
cortex tRNS would induce a larger improvement in contrast sensitivity that a-tDCS or sham. 
The secondary purpose of this pilot study was to assess the feasibility of the use of our 
stimulation apparatus on subjects, specifically, to test the tolerability of different tES 
techniques using tES apparatus that had recently been acquired by the laboratory. Lastly, this 
study aimed to assess the feasibility of measuring tES effects using contrast sensitivity for 
Landolt-C optotypes (a clinically-relevant outcome measure)  as previous studies used Gabor 
patches that lack clinical acceptability [29,89,107,108]. We did not test tACS because the 
available stimulator did not have this functionality. 
3.2 Materials and methods 
3.2.1 Subjects 
We used convenience sampling to recruit 18 healthy adults (26.7 ± 5.2yrs, 10 female) from 
graduate students in the School of Optometry and Vision Science, University of Waterloo. 
Each participant was randomized into one of three groups and underwent single session of 
visual cortex tES (anodal-tDCS, n = 6; tRNS, n = 6 and sham, n = 6). Participants had best 
corrected visual acuity of 6/7.5 or better in each eye and had no contraindication to tES 
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[33,261]. The purpose of the study and tES protocol were explained to all participants prior to 
administering treatment. Our tES protocol and procedures conformed to safety guidelines for 
tES application in humans [34]. Written informed consent was obtained from all participants. 
3.2.2 Instrument and stimuli 
The pilot study employed a Landolt-C contrast sensitivity test (LCST) presented within a set 
of  computer-based, automated vision tests (AVT) developed by the Operational Health and 
Performance Research Division, Aeromedical Research Department, U.S. Air Force School 
of Aerospace Medicine and Wright Patterson Air Force Base, Dayton Ohio[268,269]. The 
configuration and calibration of the NEC MultiSync P232W monitor used to display the 
stimuli (21.3 inches, 1920x1080 resolution, non-stereo display) was conducted using a X-
Rite i1 Display Pro colorimeter. The contrast of the Landolt-C (three stimuli: 166.67, 83.33, 
12.25 and 6.25 Arc Mins) (Figure 3) was varied (40 trials each) according to an adaptive 
procedure[270]. 
3.2.3 Experimental Design 
Participants sat in dark room at a 4-meter viewing distance from the monitor (Figure 3). 
Participants were instructed to fixate at the center of the screen when performing the task. 
The dominant eye was tested with the non-dominant eye occluded. The Landolt-C (gap in C 
oriented at four possible positions: left, right, top, or bottom) appeared on white/gray at the 
center of the screen during the contrast test and the participant’s task was to identify the gap 
location using the keyboard arrows to respond following a four alternative forced choice 
procedure. Correct and wrong responses were followed by distinct sounds, and every 10th 
trial was 50% bigger than previous trial in order to maintain attention.  LCST tests were 
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administered before tES (tRNS, a-tDCS or sham), during tES, 5 min and 30 min after 
stimulation. Each LCST session took 7-9 mins to complete. All participants performed 
practice blocks to familiarize them with the stimuli and task. Each participant spent between 
60-80 mins to complete each experiment including practice blocks.  
3.2.4 Transcranial Random Noise Stimulation 
Single session anodal-tDCS (2.0 mA, current density: 0.10 mA/cm2) or tRNS (2.0 mA, 
current density: 0.10 mA/cm2, frequency range 0.1-640 Hz) or placebo (sham) stimulation of 
the primary visual cortex for 15mins was delivered using a DC-STIMULATOR PLUS 
(Eldith, NeuroConn GmbH, Germany) through a pair of saline-soaked surface sponge 
electrodes (5 cm x 5 cm, 25 cm2)[261]. For tDCS, the current was linearly ramped up over 
30sec to 2 mA, maintained at 2 mA for 15 minutes, and then linearly ramped down to 0mA 
over 30sec[33]. For tRNS, the AC current was initially ramped up to a maximum of 2mA 
over 30 sec and ramped down to 0mA over 30 sec at the end of the stimulation session. 
During sham stimulation, the 30 sec ramp-up was immediately followed by the ramp-down 
out. For each stimulation protocol, the reference electrode (cathodal electrode for tDCS) was 
placed at Cz while the active electrode (anodal electrode for tDCS) was placed at Oz (~10% 







Figure 3:Set up of experiment showing distance of monitor and sitting chair for 
participants (left image). Monitor tES stimulation using DC-Stimulator-MC (middle 
image), and the 3 Landolt-C optotypes displayed on NEC MultiSync P232W monitor 
(right image). 
 
3.2.5 Data analysis 
Statistical analyses were performed using SPSS 19 (IBM Corp., Armonk, NY). Contrast 
sensitivity was recorded in log units. A mixed-effects analysis of variance (ANOVA) with a 
within-subjects factor of Time (pre, during, post 5 and post 30), between subject factor of 
Stimulation Type (a-tDCS, tRNS and Sham) and within subject factor of Stimulus Size (83.3 
ArcMin, 12.5 ArcMin and 6.25 ArcMin) was conducted for the contrast sensitivity data. 
Pairwise comparisons were conducted to explore significant interaction effects. A 
significance threshold of p < 0.05 was adopted for all analyses. 
3.3 Results 
The mean age distribution for each group was 27.6 ± 4.11yrs with 4 females for anodal-
tDCS, n = 6; 25.47 ± 4.10yrs with 3 females for tRNS, n = 6; and 26.26 ± 4.85yrs with 3 
females for sham, n = 6. The total mean distributions of LCST (Log Threshold) for 83.3 
ArcMin, 12.5 ArcMin and 6.25 ArcMin target sizes recorded 5 minutes before and 30 
minutes after stimulation were -1.7399 ± -0.7082 and -1.7178 ± -0.6987, -1.0113 ± -0.6634 
and -1.0848 ± -0.7175 and -0.5080 ± -0.4523 respectively. A repeated measures ANOVA 
conducted on the log contrast sensitivity thresholds showed no statistically significant 
interaction between Time (pre, during, post 5 and post 30), Stimulation Type (a-tDCS, tRNS 




Figure 4: Contrast sensitivity (Log threshold) measured at baseline (-5 mins), during (0 
min), immediately after (5mins) and 30mins after stimulation. Small and medium 
stimuli showed an increase in contrast sensitivity 5mins and 30mins respectively after 
tDCS (A), tRNS (B) and Sham (C) stimulation but this effect was not statistically 
significant. Larger (less negative) y-axis values indicate improvement in contrast 
sensitivity. Error bars shows standard error of the mean.  
 
Figure 5: Percentage change of contrast sensitivity (Log threshold) from baseline at 3 
different time points. Small and medium stimuli showed an increase in contrast 







































































































































































































































































































stimulation but this effect was not statistically significant. Larger y-axis indicates 
improvement in contrast sensitivity. Error bars shows standard error of the mean. 
 
3.4 Summary and Conclusion 
We tested the hypothesis that visual cortex tRNS would induce the largest improvement in 
contrast sensitivity compared to visual cortex tDCS and sham in healthy adults. However, 
this pilot study did not find any reliable difference between tES protocols for effects on 
contrast sensitivity for healthy adults. Our results showed small improvements for all tES 
methods for small and medium size stimuli immediately and 30 mins after stimulation, but 
these effects were not reliably different from baseline measurements. This may be due to the 
small sample size and lack of a within-subjects test of stimulation types employed in this 
pilot study. Alternatively, healthy participants may already have effective contrast sensitivity 
for the stimuli we used. Future experiments will assess whether measurable effects occur in 
patients with amblyopia who have contrast sensitivity deficits. This study was the first to test 
effects of tES methods on contrast sensitivity using Landolt-C outcome measure. The use of 
Landolt-C plays a significant role in clinical assessment of primary visual function. Previous 
studies have used gabor patch as contrast detection assessment of the effects of tES methods 
[29,89,107,108], however, the Gabor patch is not generally used clinically for assessing 
visual function of patients. Therefore, we demonstrated that the Landolt-C potentially can be 
used as an outcome measure in determining the effects of tES methods in healthy adults, and 




Finally, our stimulation protocol conformed to the safety guidelines, and subjects tolerated 
the stimulation well without reporting adverse effects. The majority of the subjects 







Chapter 4: Effects of transcranial random noise stimulation on Primary visual 
cortex in adults using EEG 
4.1 Introduction  
Transcranial random noise stimulation (tRNS) is a non-invasive brain stimulation technique 
that involves the delivery of a randomly oscillating alternating current through two head 
mounted electrodes [4,13].  tRNS has attracted interest in the fields of neurostimulation and 
neurorehabilitation because it appears to induce larger increases in neuroplasticity within 
stimulated neural systems than other transcranial electrical stimulation techniques such as 
transcranial direct current stimulation (tDCS) [97,261,271,272].  In addition, recent tRNS 
studies in tinnitus[97], visual perceptual learning [91,273] and myopia [109] have reported 




When applied to the motor cortex, tRNS induces a lasting increase in cortical excitability 
measured as an increase in the amplitude of motor evoked potentials induced by motor cortex 
transcranial magnetic stimulation [262,274]. A similar effect has been observed when tRNS 
is applied to the visual cortex. Herpich et al.[275] observed a prolonged reduction in the 
intensity of visual cortex TMS required to induce the perception of a phosphene (the 
phosphene threshold) following 20 min of visual cortex tRNS. Reduced phosphene 
thresholds represent increased visual cortex excitability. 
 
The majority of visual cortex tRNS studies have employed high frequency tRNS (hf-tRNS; 
alternation frequency between 101 and 640 Hz) [4,92,275–277]. However, previous studies 
have found no statistically significant difference between the effects of low frequency (0.1 – 
100 Hz) and high frequency tRNS applied to the visual cortex on visual perceptual learning 
[271]. Therefore, in this study, with visually normal controls, we investigated the effect of 
full spectrum tRNS on visual cortex excitability using visually evoked potentials (VEPs). We 
chose to use VEPs as our outcome measure because many individuals do not experience 
TMS-induced phosphenes [275,278] and visual electrophysiological measures are sensitive 
to the effects of other types of transcranial electric stimulation such as tDCS and transcranial 
alternate current stimulation (tACS) when applied to visual cortex [9,22,279–282].  
 
VEPs are visually evoked electrophysiological signals obtained from 
electroencephalographic activity within the visual cortex [283,284]. VEPs are used clinically 
as a diagnostic tool for diseases that affect the retina [285,286], optic nerve [287,288], optic 
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radiations [289–291] and occipital cortex [292–294]. In human research, VEPs are often used 
to study the functional integrity of the visual system. Many studies have investigated the 
cortical sources that generate the major components of pattern-reversal VEPs [295–297]. A 
number of these studies have used magnetoencephalography (MEG) [298,299] and/or 
functional magnetic resonance imaging (fMRI) [300] to identify the cortical areas that 
generate pattern-reversal VEPs. There is a general consensus that the N75 component of the 
pattern reversal VEP waveform is generated in V1[298,299,301,302]. However, V1, V2-V3 
and V3-V4 have all been associated with both the P100 and N135 [302,303].  
 
Recently, VEPs have emerged as an investigative tool to explore, electrophysiologically,  the 
effects of occipital cortex TMS [212–214], tDCS [22] and tACS [304] in humans [212] and 
animals [305]. For instance, Antal et. al. (2004) applied 10-15mins tDCS over the occipital 
cortex and recorded VEPs in response to sinusoidal luminance gratings presented in an on/off 
mode in healthy human adults. They reported a decrease in the amplitude of the N70 
component with cathodal stimulation whereas anodal stimulation increased the amplitude of 
the N70 component. Contrarily, the P100 waveform component increased in amplitude with 
cathodal stimulation whilst anodal stimulation had no effect [9]. 
 
The efficacy of tRNS in modulating cortical activity has been demonstrated, by implication, 
from perceptual and behavioral effects [109,275,276,306–309]. For instance, Herpich et 
al.[275] showed increased visual cortex excitability after high frequency tRNS. There is no 
reported objective electrophysiological evidence of the effects of tRNS in healthy human 
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occipital cortex using VEPs. Therefore, we tested the hypothesis that active tRNS would 
induce an acute increase in visual cortex excitability as evidenced by increased VEP 
amplitude.   
 
To provide a within-session control, we applied tRNS to only one cerebral hemisphere and 
presented hemifield pattern reversal stimuli to both the stimulated and unstimulated 
hemisphere. We anticipated tRNS effects to be apparent only when VEP stimuli were 
presented to the stimulated hemisphere. Although it is generally expected that hemi-field 
stimulation would induce a bigger scalp response from the contralateral hemisphere, a 
phenomenon referred to as paradoxical localization often occurs whereby the largest VEP 
responses are recorded from the hemisphere ipsilateral to the hemifield VEP stimulus. This 
effect was first identified by Halliday and Michael [310] who demonstrated that the scalp 
responses to hemi-field pattern stimulation were distributed asymmetrically. Thereafter, 
Barrett et al.[311] and Towle et al.[312] reported reliably greater amplitude of evoked 
potentials over the ipsilateral occipital cortex in response to hemi-field pattern stimulation. 
This paradoxical laterization was due to medial orientation of cortical generators within the 
visual cortex but diagonally positioned relative to the scalp surface. We anticipated that 
paradoxical localization would be apparent in our VEP datasets.  
 
Variations in peak latencies of cortical responses to pattern stimulation are dependent on 
pathological (migraine [313], optic neuritis [314], retinal disease [285,286], multiple 
sclerosis [315]) and non-pathological (age and sex [316], visual acuity [317,318], contrast 
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and luminance [317], check and field size [319–321]) conditions. Previous studies have 
reported the effects of non-invasive brain stimulation on amplitudes [9,22,212,213,280,322–
324] and peak latencies [9,281] of evoked potentials. Despite the changes of amplitudes 
induced following NIBS, Antal et al. (2004) and Accornero et al. (2007) showed that peak 
latency was statistically unchanged or not affected by NIBS, specifically tDCS. Adding to 
the body of evidence, we tested our third hypothesis that visual cortex tRNS will not affect 
peak latencies.  
 
In this study, to assess the acute effects of visual cortex tRNS, we investigated pattern-
reversal VEP waveforms (in particular the N75, P100 and N135 waveform components) in 
response to hemifield stimulation with high-contrast, black and white checkerboard reversal 
stimuli before and after active tRNS or sham treatment delivered to the left or right occipital 
cortex. We selected the pattern reversal stimulus because the waveform and timing are less 
variable than for other stimuli; hemifield stimulation allowed selective testing of the 
stimulated and non-stimulated occipital cortices.       
4.2 Materials and methods 
4.2.1 Subjects 
Ten healthy subjects were recruited from the University of Waterloo campus (6 females; 
mean age = 27.10, range 20-37 years). All subjects had no history of neurological disorders 
and no contra-indications to non-invasive brain stimulation. All subjects had normal or 
corrected-to-normal visual acuity (VA ≤ 0.1 logMAR in each eye). This study was approved 
by the University of Waterloo Office of Research Ethics, and was carried out in agreement 
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with the principles of the Declaration of Helsinki. Written informed consent was obtained 
from all subjects. 
4.2.2 Experimental Design 
All subjects attended two sessions to receive both active tRNS and sham treatment on 
different days, however, each treatment was randomized for each participant. There was a 
one week interval between active and sham data collections to eliminate any stimulation 
after-effects [35,325]. Subjects were naïve to both active and sham tRNS procedures. Each 
session included baseline (pre) and post electroencephalographic (EEG) recordings. Pre-post 
measurements were made for right and left hemi-field checkerboard stimuli as well as for 
right and left eyes (Figure 6). The right eye (left eye occluded) viewed the right hemi-field 
checkerboard stimulus which was always presented first followed by the left hemi-field 
checkerboard stimulus. The same procedure was repeated for left eye (right eye occluded).  
4.2.3 Experimental paradigm  
Four (4) EEG recordings (right eye – right hemi-field stimulus; right eye – left hemi-field 
stimulus; left eye – right hemi-field stimulus and left eye – left hemi-field stimulus) were 
collected during the pre-session and another 4 EEG recordings were collected during the 
post-session. In all sessions, the subject was seated comfortably at a desk while fixating a red 
fixation cross in the center of a computer screen, at 1-meter distance, in front of them in a 
dark room. After the baseline EEG recordings, each subject then received either active or 
sham tRNS over randomized right or left occipital hemisphere. This was followed by post 
EEG recordings. Each hemi-field checkerboard stimulus was presented for 3 mins, totaling 
12 mins of recordings for both eyes. Five minutes were used to remove the EEG cap and set 
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up the tRNS system followed by 20 mins of tRNS. Another 5 minutes was used to remove 
tRNS system and set up the EEG cap followed by 12 mins of post EEG recordings (60 
minutes in total for each subject per day session). The checkerboard stimulus was a black-
and-white checkerboard with individual check widths of 1o. The contrast between black and 
white squares was set to 100% with mean photopic luminance of 50 cd/m2.  The pattern 
reversal rate was 2 reversals per second and the diameter of the square hemi-field was 15o. 
Our recording parameters  generally conformed to ISCEV standards for clinical VEP 
recording [283]. 
4.2.4 EEG parameters  
We followed the international 10–20 system for electrode placement to measure the EEG 
activity from the surface of the scalp. Recording references were linked mastoids.  A 32-
channel EEG cap (Quick-Cap, Neuroscan, Compumedics, NC USA) was used to record EEG 
data. Continuous EEG data were gathered, filtered with a band pass of (0.2–1000 Hz), 
digitized at 1000 Hz (Neuroscan 4.5, SynAmps2, Compumedics, NC USA) and stored on a 
personal computer for offline analysis. The continuous EEG data from Neuroscan were 
imported and analyzed in EEGLAB (EEGLAB v2019.4.31). Channel labels were 
automatically allocated. In order to eliminate unnecessary noise in the data, we re-referenced 
all channels to the vertex electrode (Cz). To further reduce high-frequency noise, the data 
were filtered with a bandpass filter with a range of 1Hz and 50Hz and a sample rate of 
512Hz. Next, the pre-processed data underwent linear decomposition using independent 
components analysis (ICA). ICA decomposes the data collected at single scalp channels to a 
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spatially transformed "virtual channel" basis. After ICA, the data were epoched and the 
processed data were exported for data analysis. 
4.2.5 Transcranial Random Noise Stimulation 
Subjects either received active tRNS (2.0 mA, current density: 0.10 mA/cm, frequency range 
0.1-640 Hz) or placebo (sham) stimulation of the primary visual cortex for 20 mins. 
Stimulation was delivered using a DC-stimulation MC device (Eldith, NeuroConn GmbH, 
Germany). The stimulation was delivered via a pair of saline-soaked surface sponge 
electrodes (5 cm x 5 cm, 25 cm2) placed at Cz (blue) and either at O1 or O2 (red) (Figure 6). 
The AC current was initially ramped up to a maximum of 2mA over 30 sec and ramped 
down to 0mA over 30 sec at the end of the stimulation session. During sham stimulation, the 
30 sec ramp-up was immediately followed by the ramp-down out[33,308]. All subjects 
participated in both active and sham tRNS experimental sessions with a minimum of one-
week interval. Subjects were entirely naïve to non-invasive brain stimulation, hence, ensuring 
that subjects remained masked to their treatment allocation. Our application of tRNS 




Figure 6:  Schematic presentation of the EEG recording and tRNS protocol. The left 
panel shows the right hemi-field (RHF) visual stimuli processed in the left cortical 
hemisphere (orange arrows) and left hemi-field (LHF) visual stimuli processed in the 
right cortical hemisphere  (black arrows). Six subjects received tRNS at O2 (right 
occipital lobe)  and 4 subjects received tRNS at O1 (left occipital lobe). The right eye 
always viewed the RHF stimulus first (left eye occluded) for 3mins, followed by the 
LHF stimulus for 3mins. The same procedure was repeated for the left eye (right eye 
occluded). The right panel depicts the tRNS electrode montage. 
 
4.2.6 Data analysis 
The peak-to-peak amplitudes of the VEPs were measured within the first 400ms after pattern 
reversal. The VEP amplitudes were calculated by (i) subtracting the first negative deflection 
(N75) from the first positive deflection (P100), and (ii) subtracting the second negative 
deflection (N135) from first positive deflection (P100). We also defined each peak latency 
• 10 healthy adults 





• Right hemisphere, RH (n=6)
• Left hemisphere, LH (n=4)
tRNS = 2mA
























(N75, P100 and N135) as the time from stimulus onset to the point of maximum positive or 
negative amplitude within the latency window (0-400ms). 
We performed a repeated measures analysis of variance (ANOVA) on the VEP amplitude 
and latency data for each electrode separately using SPSS (IBM, Version 25). The ANOVA 
model had within-subject factors of CONDITON (Active vs Sham) and TIME (Pre vs Post). 
We also compared mean amplitudes for EYE (Right Eye vs Left Eye) and ELECTRODE (( 




Visual stimulus No visual stimulus 
tRNS CoP8, CoO2 IpO2, IpP8  

































Subjects received tRNS at right hemisphere 4 subjects received tRNS at left hemisphere




Figure 7: Schematic of the relationship between tRNS location, cerebral hemisphere 
and EEG electrode position for tRNS of the right hemisphere.  Electrode notations were 
reversed for subjects who received tRNS over the left hemisphere. Each occipital 
hemisphere is described as either ipsilateral (orange) or contralateral (black) to the 
hemi-field checkerboard stimulus. We analyzed 5 electrodes placed over the occipital 
cortex (CoO1/2 – Contralateral O1 or O2; Oz; IpO1/2 – Ipsilateral O2 or O1; CoP7/8 – 
Contralateral P7 or P8; and IpP7/8 – Ipsilateral P7 or P8). The 2x2 table shows the 
relationship between electrodes, tRNS and visual stimulation. 
 
 





4.3 Results  
There were no adverse effects of tRNS, however, a majority of the subjects reported mild 
tingling sensations under the electrodes during both active and sham sessions. The VEP 
amplitudes for right and left half-field pattern reversals were recorded in ten subjects, 
however, one subject was excluded from the data analysis due to the presence of high-
frequency noise in the EEG data (Figure 8).  
Example individual (blue) and grand averaged (black) waveforms at the midline (Oz) from 
all 9 subjects are presented in Figure 9. Each individual waveform represents a standard 






Figure 9: Individual (blue waveform) and averaged (black waveform) VEP recorded by 
the Oz (midline) electrode for all 9 subjects after active tRNS. 
 
4.3.1 Paradoxical localization of hemi-filed pattern-reversal VEPs 
For both active and sham conditions and for both eyes pre and post tRNS, we observed 
paradoxical localization of the hemi-field VEPs. Specifically, there was an asymmetric 
distribution of N75-P100 and -N135 amplitudes across the 5 electrodes. The largest 
amplitudes were at Oz with a sharp decline for the electrodes contralateral to the hemi-field 
pattern-reversal visual stimulus. A similar pattern was evident for the latency data, whereby 
longer latencies were observed ipsilateral to the hemi-field VEP stimulus  (Figures 10 to 14).  
 
4.4 VEP checkerboards presented to the occipital hemisphere that received tRNS 
Significant effects of tRNS were observed for data from the lateral scalp electrodes ipsilateral 
to the VEP hemifield stimulus for the right eye viewing condition only. For the N75-P100 
amplitude data, a significant interaction between Condition and Time (F1,8 =18.451, p = 
0.003) was observed (Figure 10A & B). The same interaction was also observed for the 
P100-N135 amplitude data (F1,8 =10.195, p = 0.013). A significant main effect of Condition 
(F1,8  = 9.708, P = 0.014) was also present whereby amplitudes were larger for the active 
tRNS session at both timepoints.  No other main effects or interactions reached significance.  
Figure 12 illustrates group averaged VEP waveforms for the lateral electrodes placed 
ipsilateral to the hemi-field stimulus for the right eye viewing condition. There were no 







Figure 10:  Amplitudes of VEPs to the right eyes (RE) and left eyes (LE) when VEP 
checkerboard stimuli were presented to the occipital hemisphere that received active / 
sham tRNS. A (upper panel):VEP amplitudes for  N75-P100 (mean ± within subject 
standard error of the mean (SEM)). B (lower panel): VEP amplitudes for P100-N135). 





Figure 11: Peak latencies of VEPs when VEP checkerboard stimuli were presented to 
the occipital hemisphere that received active / sham tRNS. Panel A shows P100 peak 
latencies and panel B shows N135 peak latencies (mean ±SEM). *Statistically significant 





Figure 12:  Group averaged VEP waveforms illustrating the Condition x Time 
interaction effects for electrode IpP7. Averaged VEP waveforms for other electrode 
sites can be found in supplementary figures: Appendix 1) 
 
 
4.5 VEP checkerboards presented to the occipital hemisphere that did not receive tRNS 
No significant interactions or main effects were observed for the VEP amplitude or latency 
datasets when the VEP checkerboard stimulus was presented to the occipital hemisphere that 





Figure 13: Amplitudes of VEPs when VEP checkerboard stimuli were presented to the 
occipital hemisphere that did not receive active / sham tRNS.  A (upper panel) shows 







Figure 14: Peak latencies of VEPs when VEP checkerboard stimuli were presented to 
the occipital hemisphere that did not receive active / sham tRNS. Panel A shows P100 
peak latencies and panel B shows N135 peak latencies (mean ±SEM). 
4.6 Discussion  
The aim of this study was to investigate the effects of tRNS on visual cortex excitability 
using pattern reversal hemifield VEPs. Active tRNS induced increases in VEP amplitude 
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relative to sham tRNS for both N75 to P100 and P100 to N135 amplitude components when 
visual stimuli were presented to the hemisphere that received tRNS. Our results supported 
our hypothesis that visual cortex tRNS would enhance VEP amplitudes in healthy adults. Our 
observation that visual cortex tRNS increased the amplitudes of VEPs is consistent with 
other studies reporting enhanced amplitudes of motor evoked potentials (MEPs) following 
motor cortex tRNS [4]. Increased MEP and VEP amplitudes are consistent with increased 
excitability within the cortical neurons.  
 
When the VEP right eye checkerboard stimulus was presented to the occipital hemisphere 
that received active / sham tRNS, ipsilateral occipital electrodes exhibited significant tRNS 
induced changes in VEP amplitude that were driven by a small increases post-stimulation in 
the active condition and a larger drop for the sham condition. The relative decrease in VEP 
amplitude post tRNS for the sham condition maybe attributed to adaptation and/or fatigue 
effects [181,327]. Several studies have reported VEP habituation in control subjects as a 
result of repeated checkerboard visual stimulation [313,328–330]. For instance, Áfra et 
al.[313] observed a progressive decrease in VEP amplitudes in control subjects following 15 
min of repeated pattern reversal stimulation. Interestingly, normal VEP habituation is not 
present in patients with migraine [331,332] or chronic pain [313,330]. In this study, we 
observed habituation of the VEP response in the sham tRNS condition and habituation 




The VEP results were similar for the right and left eye viewing conditions, however, there 
were no significant tRNS induced changes in VEP amplitudes for any electrode recordings 
for the left eye viewing condition. VEPs during the left eye viewing condition were recorded 
12 mins after the right eye viewing condition (right eye viewing condition’s recordings lasted 
for 12 mins) or 17 mins after occipital tRNS (5 mins was used to switch from removing 
tRNS stimulation apparatus/setup to EEG recording setup). We therefore postulate that the 
acute effects of tRNS were evident for the right eye viewing condition but were attenuated 
for the left eye viewing condition.  
 
 Recently, a number of publications have reported that visual cortex tRNS improves contrast 
detection [37,264,333], visual acuity [107,109], and perceptual learning [91,109,276]. The 
potential mechanism of tRNS aftereffects within the cortical neurons is unclear. tRNS 
aftereffects may be explained by repeated opening and closing of sodium channels leading to 
membrane depolarization and an increase in cortical excitability that outlasts the stimulation 
itself [4]. Chaieb et. al., 2015, demonstrated that tRNS aftereffects are independent of 
NMDA-receptors, but dependent on modulation of gated sodium-ion channels. This implies 
that tRNS aftereffects may not rely on LTP-like mechanisms but rather on mechanisms 
related to sodium channel function.  
 
Earlier studies reported cortical sources that generate major components of pattern reversal 
VEPs (29–31). The N75 component of pattern reversal VEPs is generated in V1 
(32,33,35,36) whilst P100 and N135 are generated in V1 to V4 (6,37). Our observation that 
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active tRNS increased the amplitude of both the N75 to P100 and P100 to N135 VEP 
components suggests that tRNS influenced excitability in neurons located in V1 to V4. Our 
results are similar to studies that used VEPs to investigate the aftereffects of tDCS within the 
occipital cortex. Antal et. al., 2004 reported anodal and cathodal visual cortex tDCS 
increased the amplitude of the N70 and P100 components respectively [9]. Similarly, Ding 
et. al., 2016 showed that the aftereffects of visual cortex anodal tDCS increased VEP 
amplitudes for amblyopic, fellow and control eyes whilst cathodal tDCS decreased these 
amplitudes [22].  
 
We observed paradoxical localization of the hemi-field VEPs, specifically an asymmetric 
distribution of N75-P100-N135 amplitudes across the occipital electrodes with largest 
amplitudes at the midline electrode (Oz) and with a sharp decline on the same side as the 
processing hemisphere (contralateral to the hemi-field pattern-reversal) and a more gradual 
decline opposite to the hemisphere processing the pattern-reversal. The data presented here 
are consisted with those of Barret et al.[311] who reported that higher amplitude visually 
evoked responses occurred at the occipital electrodes placed over the hemisphere ipsilateral 
to the pattern reversal stimulus. Paradoxical laterization is explained by the locations of 
cortical generator regions which are mainly positioned on the medial and posteromedial 
surface of the occipital cortex. The occipital electrodes placed over the ipsilateral hemisphere 
record optimal evoked responses from these cortical generators, however, cortical electrodes 
placed over the contralateral hemisphere are almost vertical to the axis of the cortical 




We also investigated the aftereffects of tRNS on peak latencies, and we observed that visual 
cortex tRNS did not induce statistically significant early or prolong peak latencies for either 
P100 or for N135 VEP components. N75 was either absent (not below baseline) or very low 
amplitude, rendering the peak latency unreliable and, therefore, N75 data were not analyzed. 
We do not have available evidence that tRNS aftereffects shift the timing of peaking 
latencies. VEP peak latencies are delayed by obstructions in the visual 
pathway[288,289,292,335] and by retinal diseases[285,286]. In this study, timing of the peak 
latencies may not have been affected by tRNS effects because we recruited healthy subjects. 
Another possible explanation is that tRNS aftereffects are not known to change the speed of 
action potential conduction. However, tRNS aftereffects directly affect the membrane 
potential of the neuronal cells leading to increase firing rates and subsequently resulting in an 
increase in excitability within the neural circuits[4].  
4.7 Study limitations 
There are two major limitations in this study that could be addressed in future research. First, 
there was non-randomization of the testing order of the eyes when viewing the hemi-field 
checkerboard stimuli. Our left eye data did not show significant differences in VEP 
amplitudes. If the effects of tRNS are brief, then a stronger effect for the eye tested first is 
would account for the effect in the right eyes only as these were recorded first for both pre 
and post treatment. Second, the small sample size in this study may have not provided 
sufficient statistical power to observe reliable effects of tRNS at all the scalp electrodes 
placed ipsilateral to the checkerboard stimulus for both right and left eye viewing conditions. 
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Finally, because this was an exploratory study with a large number of variables, the statistical 
results reported were not corrected for multiple comparisons and therefore there is the risk of 
type 1 error. Based on the current results, future studies can identify a more targeted set of 
variables and outcome measures to avoid a large number of statistical comparisons.  
4.8 Conclusions 
Visual cortex tRNS induced excitability changes in healthy human adults. Our results are 
consistent with previous studies that used VEPs to investigate the effects of transcranial 
direct current stimulation. This study supports the evidence that tRNS can induce 
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5.1 Introduction 
Amblyopia is a developmental disorder of the visual cortex, with a prevalence of 
approximately 1-5% [52,53,336]. Amblyopia causes a wide range of vision deficits [41,47] 
including a monocular loss of high-contrast visual acuity [42,45] that is particularly 
pronounced for crowded optotypes [337,338], reduced contrast sensitivity in the affected eye 
[42,339–341], and impaired or absent stereopsis [342,343]. Amblyopia is also associated 
with chronic suppression of the affected eye [39,56] that may play a key role in the etiology 
of the disorder [59].  
 
Amblyopia involves abnormal processing within the primary and extrastriate visual cortex 
[344] and therefore recovery from amblyopia requires a change in cortical function. Current 
amblyopia treatments achieve this by directly manipulating visual input to the brain. For 
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example, the most common amblyopia treatment involves the provision of a clear retinal 
image in the amblyopic eye using refractive correction followed by occlusion of the non-
amblyopic eye. This treatment improves amblyopic eye visual acuity, but has drawbacks in 
terms of compliance [150] and reduced efficacy with increasing age [345].  
 
Transcranial electrical stimulation (tES) refers to a suite of non-invasive neuro-modulation 
techniques including transcranial direct current stimulation (tDCS), transcranial alternating 
current stimulation (tACS) and transcranial random noise stimulation (tRNS) that may 
enhance plasticity in targeted regions of the human brain [4,13,261], including the visual 
cortex [89,108,109].  Currently, tES methods are being investigated as a potential 
neurorehabilitation tool for disorders including stroke [175,177–179], chronic pain [172,173] 
and tinnitus [97,174] and there is growing interest in the use of tES and transorbital 
stimulation to treat disorders of vision (see [208,209,346,347] for recent reviews).  
Following early work that reported improved contrast sensitivity in adults with amblyopia 
after visual cortex transcranial magnetic stimulation [10,20], a number of studies have 
investigated the application of anodal tDCS to amblyopia. A single session of anodal tDCS 
improves amblyopic eye contrast sensitivity [21,22], increases visually evoked potential 
(VEP) amplitudes induced by stimuli presented to the amblyopic eye [22], and balances the 
response to inputs from each eye within visual cortex [21]. Furthermore, anodal tDCS 
enhances the effect of perceptual learning (PL) in adults with amblyopia [89] and recent 
studies have revealed that visual acuity, detection thresholds, and stereopsis improve in 
mature amblyopic rats following anodal tDCS [62,64,132]. One potential mechanism for 
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anodal tDCS effects in adults with amblyopia is a reduction in GABA-mediated inhibition 
[168] within the visual cortex. GABA has been associated with interocular suppression in 
strabismic cats [57] and may act as a “break” on visual cortex plasticity [60].   
 
A recently developed tES technique, tRNS, involves an alternating current that randomly 
changes in frequency and amplitude [260]. tRNS may have larger effects on cortical activity 
than other tES protocols. For example, tRNS induced significantly greater improvements in 
tinnitus symptoms [97] and larger increases in motor evoked potential amplitude (MEP) 
[261] compared to either tDCS or tACS. Furthermore, visual cortex tRNS enhanced visual 
perceptual learning in adults with normal vision to a greater extent than anodal tDCS 
[91,272] and the combination of tRNS and perceptual learning enhanced the transfer of 
learning to non-trained visual tasks in adults with amblyopia [24]. tRNS has also been 
reported to enhance visual perceptual learning in adults with cortical blindness [272]. 
Potential mechanisms for these effects include an acute enhancement of the signal-to-noise 
ratio within the visual cortex due to stochastic resonance [28,308,348] and longer-lasting 
alterations in neural membrane function due to repetitive opening and closing of sodium 
channels [14]. 
 
Within this single-blind, between subjects, randomized, sham-controlled study, we tested the 
hypothesis that five daily sessions of visual cortex tRNS alone would lead to improved 
amblyopic eye contrast sensitivity, crowded and uncrowded amblyopic eye visual acuity in 




5.2 Methods and materials  
5.2.1 Participants 
Amblyopia was defined as reduced best corrected visual acuity (> +0.3 logMAR) in one eye 
in the absence of ocular pathology and at least a 0.2 logMAR acuity difference between the 
eyes.  Anisometropia was defined as a difference in spherical equivalent between the two 
eyes of  0.50 Diopters (D), or a difference of astigmatism in any meridian  1.50 D [155].  
Initial visual acuity was measured using an M&S logMAR chart. Inclusion criteria were: (i) 
presence of strabismic and/or anisometropic amblyopia; (ii) 0.0 logMAR visual acuity or 
better in the fellow eye (FE). Exclusion criteria [34,325,326,349] were: (i) presence of a 
scalp skin condition that contraindicated tRNS; (ii) history of neurological or psychiatric 
disorders, such as seizures; (iii) current medication for the treatment of neurological or 
psychiatric disorders; (iv) a history of brain injury; (v) implanted medical devices.  Potential 
participants were contacted following a search of the clinic’s patient database. Interested 
participants completed telephone screening to determine eligibility. The experimental 
procedures were approved by the Ethics Review Board of the University of Waterloo, 
Canada and were consistent with the declaration of Helsinki. Written informed consent was 
obtained from all participants. All participants were remunerated for their time. Two subjects 





Table 2: Participant details. M = male, F = female, patching = previous history of 
occlusion therapy, mixed = mixed amblyopia, aniso = anisometropic amblyopia, strab = 
strabismic amblyopia, stereoacuity is presented in seconds of arc, AME = amblyopic 
eye, FFE = fellow fixating eye, add = near power addition. 
ID Age/
sex 
Patching Type of 
amblyopia 
Stereoacuity Visual acuity 
(logMAR) 
Current refraction 
     AME FFE AME FFE ADD 
AG1 27/
M 
Yes Mixed <800 +1.40 0.00 +2.00 -0.50 x 155 +0.50 DS  
AG2 20/
M 
Yes Aniso 400 +0.50 0.00 +1.00 -1.50 x 175 Plano  
AG3 37/
M 
Yes Aniso <800 +0.30 0.00 -1.00 -1.00 x 100 -0.25 -2.50 x 090  
AG4 45/F Yes Aniso 200 +0.30 0.00 +2.75 -0.75 x 080 +2.00 -0.25 x 159 +1.50 
AG5 59/
M 
No Aniso <800 +0.70 0.00 +8.25 DS +8.25 -1.25 x 105  +2.50 
AG6 41/F Yes Mixed <800 +0.50 0.00 +2.00 DS +0.25 -3.75 x 179  +0.75 
AG7 46/
M 
No Aniso <800 +0.40 0.00 +0.75 DS +4.25 -0.50 x 165  
AG8 52/F No Aniso 400 +0.70 0.00 +0.50 -0.50 x 175 +2.00 -0.50 x 075  +2.25 
SG1 51/F Yes Mixed <800 +0.30 0.00 +3.25 -0.50 x 165 Plano   
SG2 58/
M 
Yes Aniso 400 +0.30 0.00 +4.00 -0.25 x 180 +1.50 -0.50 x 180  +2.25 
SG3 52/F No Aniso 200 +0.40 0.00 -2.50 -0.50 x 155 -1.50 DS  +2.75 
SG4 19/
M 
No Aniso <800 +0.30 0.00 +2.25 DS +0.75 DS  
SG5 55/
M 
No Aniso <800 +0.30 0.00 +1.75 -0.75 x 085 +1.75 -0.75 x 090  +2.00 
SG6 49/
M 
No Strab 100 +0.30 0.00 +1.75 DS +1.50 DS  
SG7 24/
M 
No Mixed <800 +0.30 0.00 +8.25 -2.00 x 160 +6.50 -1.25 x 0.40  
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A single-blind, sham controlled, between-subjects design was adopted. Randomization 
followed allocation concealment procedures and was conducted by an experimenter who was 
not involved in data collection or eligibility assessment using a random number generator. 
Randomization occurred after participants had met the eligibility criteria and completed 
study enrolment. Participants completed 5 consecutive daily stimulation sessions and a 
follow-up session 28 days after the final stimulation session. Outcome measures were 
completed by the participants using automated computer programs with no input from the 
experimenter. This procedure was designed to mitigate against experimenter bias. 
5.2.3 Transcranial Random Noise Stimulation 
Subjects either received tRNS (2.0 mA, current density: 0.08 mA/cm, frequency range 0.1-
640 Hz) or placebo (sham) stimulation of the primary visual cortex for 25 min over 5 
consecutive days. Stimulation was delivered using a DC-stimulation MC device (Eldith, 
NeuroConn GmbH, Germany). We chose a relatively long and high intensity stimulation 
protocol because we planned to measure 6 outcomes (contrast sensitivity, crowded and 
uncrowded visual acuity for each eye) and therefore attempted to maximize the duration of 
the stimulation aftereffects [88,237]. There is no statistically significant difference between 
the effect of high frequency (101-640 Hz) and low frequency (0.1-100 Hz) visual cortex 
tRNS on visual perceptual learning enhancement [91]. Therefore, we chose to deliver the full 
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frequency range. The stimulation was delivered via a pair of saline-soaked surface sponge 
electrodes (5 cm x 5 cm, 25 cm2) placed at Cz and Oz [7], as determined by the international 
10/20 electroencephalogram system. The AC current was initially ramped up to a maximum 
of 2mA over 30 s and ramped down to 0mA over 30 s at the end of the stimulation session. 
During sham stimulation, the 30 s ramp-up was immediately followed by the ramp-down out 
[33]. Our between subjects design and use of participants entirely naïve to non-invasive brain 
stimulation ensured that participants remained masked to their treatment allocation. Our 
application of tRNS conformed to tDCS safety guidelines [35,325].  
 
After the final tRNS sessions, participants were asked to rate the following sensations on a 
four-level scale (none, mild, moderate and severe): headache, neck pain, scalp pain, tingling, 
itching, burning sensation, sleepiness, trouble concentrating and acute mood change. 
Participants were also asked to rate whether any reported sensations were due to tES by 





Figure 15: CONSORT flow diagram for the study 
 
5.2.4 Visual Function Measurements 
Monocular contrast sensitivity and visual acuity (both crowded and uncrowded) were 
measured for each eye before, during, 5 min post, and 30 min post stimulation on each 
stimulation day (Figure 16). All measurements were made using Landolt-C optotypes 
presented using the Freiburg Vision Test (‘FrACT’) [350,351] software package on a 
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MacBook Pro (Version 10.13.6, 13-inch, 2.7 GHz, 2560 x 1600). Gamma correction was 
conducted using a Spyder photometer and the FrACT software provided 10 bits of contrast 
resolution The Landolt-C optotype was presented at 8 possible orientations and viewed from 
3 m in a dark room. Participants identified the gap orientation using button presses. Trials 
were self-paced with a maximum display time of 30 s.  A Bayesian adaptive (“Best PEST”) 
algorithm controlled optotype size for the crowded and uncrowded visual acuity threshold 
measurements and optotype contrast for the contrast sensitivity threshold measurement. Each 
threshold measurement lasted approximately 3 mins. For the measurements made during 
stimulation, threshold measurement started 5 minutes into the stimulation. Landolt-C gap 
width was fixed at 30 arcmin for the non-amblyopic eye and 100 arcmin for the amblyopic 
eye during the contrast sensitivity measures. These parameters were based on pilot 
observations in individuals with moderate and severe amblyopia who could not resolve the 
30 arcmin stimuli. Crowded optotypes were surrounded by a circle. Both the fellow eye and 
amblyopic eye were tested monocularly with the fellow eye tested first within each block. 
Uncrowded visual acuity was tested first within each block followed by crowded visual 




Figure 16: Testing and stimulation protocol.  Each measurement was recorded before 
stimulation (pre-test), during stimulation, 5 min after stimulation (Post 5 mins) and 30 
min after stimulation (Post 30 mins) for 5 consecutive days (middle column) Baseline 
(pre-test) measurements were recorded again for each eye 28 days (Day 28) after the 
last stimulation session. Stimulation was delivered for 25 mins at 2.0mA (right column). 
Active and reference electrodes were placed at Oz and Cz respectively. VA = visual 
acuity. 
 
5.3 Data Analysis 
Statistical analyses were performed in R (R Core Team, 2020) [352] using the Bootstrap-
Coupled Estimation package [353]. Visual acuities were recorded in logMAR units. Contrast 
sensitivity was recorded in log units. To test for tRNS effects within the 5 stimulation 





Group (active vs sham), a within-subjects factor of Day (day 1-5), and a within-subjects 
factor of Time (baseline, during, post 5 and post 30 mins) was conducted for each 
measurement type for each eye separately. Planned pairwise comparisons (least significance 
difference test) between baseline and all other timepoints were examined for each day. In 
addition, to assess whether tRNS had cumulative or long-term effects on visual function, a 
mixed ANOVA with factors of Group (active vs sham) and Baseline (baseline day 1, 
baseline day 2, baseline day 3, baseline day 4, baseline day 5, baseline day 28) was 
conducted for each outcome measure for each eye. All ANOVA analyses reported passed 
Levene’s test for equality of variances (p>.05) and test of sphericity (p>.05). 
Pairwise comparisons were conducted using the effect size Hedge’s g by bootstrap estimation 
(5000 bootstrap samples with replacement), with the 95% confidence interval around the g 
being bias-corrected and accelerated [353]. The permutation P values reported are calculated 
with 5000 reshuffles of the baseline and test labels performed for each permutation, with the 
P-value indicating the likelihood of observing the mean difference, if the null hypothesis of 
zero difference is true, at an a of .05. Between group differences in the strength of any 
sensations induced by tRNS were assessed using the chi-squared test.  
 
Table 3: Subjective experiences reported by participants after the day 5 active or sham 
tRNS session. 
 Mild Moderate Chi-Square (X2) 
Headache  
0.060 Active (N=9) 1 4 
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Sham (N=8) 2 0 
Neck pain  
0.466 Active (N=9) 2 0 
Sham (N=8) 1 0 
Scalp pain  
0.279 Active (N=9) 1 0 
Sham (N=8) 0 0 
Tingling sensation  
0.460 Active (N=9) 4 3 
Sham (N=8) 6 1 
Itching  
0.277 Active (N=9) 4 2 
Sham (N=8) 5 0 
Burning sensation  
0.074 Active (N=9) 2 3 
Sham (N=8) 1 0 
Sleepiness  
0.751 Active (N=9) 2 1 
Sham (N=8) 3 2 
Trouble concentrating  
0.330 Active (N=9) 0 0 
Sham (N=8) 1 0 
Acute mood change  
0.330 Active (N=9) 0 0 
Sham (N=8) 1 0 
Others Jaw stiffness Neck tension  
0.289 Active (N=9) 1 1 
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Sham (N=8) 0 0 
Any of the symptoms 
related to tES 
 Remote Probable Definite   
0.073 
Active (N=9) 0 3 6 
Sham (N=8) 2 0 6 
 
5.4 Results  
Nineteen healthy adults with amblyopia were recruited. Two participants in the sham group 
withdrew from the study after day 1 due to the time commitment required and were excluded 
from the analysis (Figure 15). Clinical details of the remaining seventeen participants are 
provided in (Table 2). A technical error prevented an accurate amblyopic eye contrast 
sensitivity measurement on day 1 for one participant in the active group. This participant was 
excluded from the amblyopic eye contrast sensitivity analysis only (Figure 15).  There was 
no statistically significant group difference in age for the 17 participants that completed the 
study (Active group mean age = 38.7 yrs., SD = 13.6; Sham group mean age = 45.8 yrs., SD 
= 15.4; t15 = 1.0, p = 0.3). There were no adverse effects of tRNS, and there were no 
statistically significant between-group differences in the range or severity of subjective 
sensations reported (Table 3). 
5.4.1 Contrast Sensitivity 
For the amblyopic eyes (Figure 17- upper panel), there was a significant interaction between 
Group and Time, F3,42 = 3.584, p = .022, ηp
2 = .216. No other omnibus main effects or 
interactions were significant. Planned pairwise comparisons between baseline and all other 
timepoints were examined for the active and sham groups for each day. During day 1, the 
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active group exhibited a significant improvement in contrast sensitivity from baseline for all 
post-test measurements (during: g =.272 [.195, .597], p = 0.01; post 5 min: g =.236 [.039, 
.726], p = .035; and post 30 min: g = .438 [.052, 1.207], p = 0.034: Figure 18). No 
significant differences between baseline and any post-test were found for days 2-5. No 
significant differences between baseline and any post-test were found within the sham group 
for any day. 
 
For the fellow eyes (Figure 18- lower panel), there was a significant interaction between 
Group and Time, F3,45 = 3.303, p = .029, ηp
2 = .191. No other omnibus main effects or 
interactions were significant. During day 1, the active group exhibited a significant 
improvement in contrast sensitivity from baseline for the post 5 min (g = .639 [.127, 1.248], 
p = 0.033) and post 30 min (g = .846 [.199, 1.661], p = 0.018) measurements. No significant 
differences between baseline and any post-test were found for days 2-5. No significant 





Figure 17: The effects of tRNS on contrast sensitivity during each daily session and at 
the day 28 follow-up visit. Data are shown separately for the amblyopic (top row) and 
fellow (bottom row) eyes and for the active (left column) and control (right column) 
groups at baseline (B) and during (D), 5 min (P5) and 30 min (P30) post tRNS. 
*Statistically significant difference from baseline (p < 0.05).  Error bars show within-
subject standard error of the mean (SEM). The dashed horizontal lines represent the 
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Figure 18: Paired Hedges' g for three comparisons (during stimulation, Post 5 mins, 
Post 30 mins) to pre-test contrast sensitivity are shown using a Cumming estimation 
plot. Raw contrast threshold data for each participant are plotted on the upper axes; 
each paired set of observations is connected by a line. On the lower axes, paired 
Hedges’s g is plotted as a bootstrap sampling distribution. Hedge’s g value is depicted 





5.4.2 Uncrowded Visual Acuity 
For the amblyopic eyes (Figure 19- upper panel), there was a significant interaction between 
Group and Time, F3,45 = 3.325; p = .029, ηp
2  = .192). No other omnibus main effects or 
interactions were significant. During day 1, the active group exhibited a significant 
improvement in uncrowded visual acuity from baseline for all post-test measurements 
(during: g =.224 [.084, .575], p=.010; post 5: g = .281 [.009, .640], p= .05; post 30: g = .307 
[.118, .795], p = .003). During days 2 and 3, the active group exhibited a significant 
difference between baseline and only the post 5 min measurement (day 2: g = .231 [.091, 
.383], p = .015, day 3: g = .126 [.003, .304], p = .038). No significant differences between 
baseline and any post-test were found during days 4 and 5. No significant difference between 
baseline and any post-test was found within the sham group for any day. By chance, there 
was a substantial difference in baseline uncrowded Landolt-C visual acuity between the 
active and sham group (compare the dashed lines in Figure 19- upper panel).  
 
For the fellow eyes (Figure 19- lower panel), there was a significant interaction between 
Group and Time, F3,45 = 3.504; p = .023, ηp
2  = .200. No other omnibus main effects or 
interactions were significant. During day 1, the active group exhibited a significant 
improvement in contrast sensitivity from baseline for the post 5 (g = .817 [.164, 1.75], p = 
0.035) and post 30 (g = .774 [.199, 1.54], p = 0.02) min measurements. No significant 
differences between baseline and any post-test were found for days 2-5. No significant 





Figure 19: The effects of tRNS on uncrowded visual acuity during each daily session 
and at the day 28 follow-up visit. Data are shown as in Figure 33. Lower (smaller/more 
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5.4.3 Crowded Visual Acuity 
For the amblyopic eyes (Figure 20- upper panel), there were no significant main effects or 
interactions (all p > 0.05).  No significant changes from baseline were observed for any day 
for any group.  As for uncrowded visual acuity, there was a substantial difference in baseline 
performance between the two groups that occurred by chance during randomization. 
 
For the fellow eyes (Figure 20- lower panel), there was a significant interaction between 
Group and Time, F3,45 = 5.733; p = .002, ηp2  = .291. No other omnibus main effects or 
interactions were significant. During day 1, the active group exhibited a significant 
improvement in crowded acuity from baseline for the post 5 (g = .404 [.083, .9], p = 0.05) 
and post 30 min (g = .457 [.09, .913], p = 0.039) measurements. During days 3 and 5, the 
active group exhibited a significant improvement in crowded acuity from baseline to post 5 
min (g = .389 [.065, 1.06], p = .007) and post 30 min (g = .721 [.047, 1.4], p = .044) 
respectively.  No significant differences between baseline and any post-test were found for 
days 2 and 4. No significant differences between baseline and any post-test were found for 




Figure 20: The effects of tRNS on crowded visual acuity during each daily session and 
at the day 28 follow-up visit. Data are shown as in Figure 33. Lower (smaller/more 
negative) y-axis values indicate better crowded visual acuity. 
 
5.4.4 Cumulative and long-term effects of tRNS 
For the amblyopic eyes, there was a significant interaction between Group and Baseline for 
uncrowded visual acuity (F5,65 = 3.372; p = .009, ηp
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active group revealed a significant difference between the day 1 baseline and the day 3 (g = 
.372 [.163, .771], p = 0.011), day 4 (g = .461 [.243, .93], p < 0.003), day 5 (g = .369 [.065, 
.809], p = 0.034), and day 28 (g = .454 [.219, 1.03], p = 0.003) baselines. However, no 
pairwise comparisons were significant for the sham group. There were no significant 
interactions for amblyopic eye contrast sensitivity or crowded visual acuity measurements or 
any of the fellow eye measurements.  
 
5.5 Discussion 
Our results partially supported our experimental hypothesis that five daily sessions of visual 
cortex tRNS would improve amblyopic eye contrast sensitivity as well as crowded and 
uncrowded visual acuity in adult patients. We observed tRNS-induced improvements in 
contrast sensitivity and uncrowded visual acuity relative to the sham group for both 
amblyopic and fellow eyes. Crowded visual acuity improved for the fellow but not the 
amblyopic eyes. Across all outcome measures, pairwise comparisons revealed that acute 
tRNS effects were statistically significant on day 1 but became non-significant for later 
sessions. Only amblyopic eye uncrowded visual acuity exhibited a lasting effect of tRNS at 
follow-up. Our discussion will focus primarily on the results for contrast sensitivity because 
initial baseline performance was matched between the groups. There were pronounced 
between-group baseline differences for amblyopic eye uncrowded and crowded visual acuity 
that occurred by chance during the randomization procedure (randomization occurred before 
baseline measures were conducted). The difference in baseline performance for the acuity 
outcome measures make it difficult to properly segregate tRNS effects from task learning 
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effects. One reason for these baseline differences might be a difference in the proportion of 
patients with anisometropic amblyopia in active (78%) and sham (50%) groups. However, a 
much larger scale study will be required to determine whether amblyopia subtype influences 
the response to visual cortex tRNS.  
 
5.5.1 tRNS-induced improvements in contrast sensitivity  
Our observation that visual cortex tRNS improved amblyopic eye contrast sensitivity is 
consistent with a growing literature reporting improved contrast sensitivity, visual acuity, 
stereopsis, and an enhanced cortical response to amblyopic eye inputs following non-invasive 
visual cortex stimulation in adults with amblyopia [8,10,20–22,89,90]. A number of potential 
mechanisms have been proposed for tRNS effects. These include stochastic resonance and 
changes in the resting membrane potential [4,28]. Stochastic resonance refers to an 
improvement in signal to noise ratio when a certain amount of noise (in this case neural noise 
induced by tRNS) is added to non-linear systems [348]. A number of psychophysical studies 
have provided compelling evidence that stochastic resonance occurs during visual cortex 
tRNS [108,309,354,355]. It is possible that the during-stimulation improvements we 
observed on day 1 for amblyopic eye contrast sensitivity were due to stochastic resonance. 
However, tRNS aftereffects (i.e., effects that outlast the duration of stimulation) cannot easily 
be explained by stochastic resonance.  
 
Terney et al.,2008 proposed that increased motor cortex excitability following tRNS is 
related to the activity of sodium channels within the neural membrane [4]. Specifically, they 
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proposed that tRNS may cause repetitive membrane depolarization that is sufficient to 
repeatedly open sodium channels but sub-threshold for generating an action potential. These 
synchronized local depolarizations were further hypothesized to induce lasting long-term 
potentiation-like effects at the level of individual neurons. However, a subsequent study 
found that pharmacological manipulation of NMDA receptors had no effect on tRNS 
aftereffects, whereas the GABA agonist lorazepam and carbamazepine, a sodium channel 
blocker, attenuated tRNS aftereffects [171]. These results are not consistent with a 
mechanism related to long-term potentiation but do support the involvement of sodium 
channels. Alternative mechanisms for the effects of electrical stimulation have also been 
proposed including regional increases in cortical blood flow [208], modified brain 
connectivity [241] and changes in neurotransmitter concentration [168,169]. The precise 
underlying mechanism for the tRNS aftereffects we observed remains to be determined.  
 
A previous study [36] reporting improved amblyopic eye contrast sensitivity following both 
excitatory and inhibitory visual cortex rTMS proposed a mechanism linked to cortical 
homeostasis. According to this hypothesis, excitatory stimulation has a more pronounced 
effect on weakly activated/suppressed neural populations whereas inhibitory stimulation has 
a greater effect on strongly activated populations. Therefore, both excitatory and inhibitory 
stimulation are capable of restoring a level of homeostasis to the amblyopic visual cortex by 
reducing the difference in activation between amblyopic eye dominated neurons (weak 
activation/suppression) and fellow eye dominated neurons (strong activation) [21].  This, in 
turn, reduces suppression and/or the relative attenuation of amblyopic-eye-driven neural 
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activity. It is plausible that the excitatory tRNS we employed in this study acts through a 
homeostatic mechanism.  
 
We also observed improved fellow eye contrast sensitivity in the tRNS group relative to the 
sham group. Non-invasive visual cortex stimulation studies have reported varying fellow eye 
effects. Studies using inhibitory stimulation protocols (1 Hz rTMS and continuous theta burst 
stimulation; cTBS) have reported reduced fellow eye contrast sensitivity [35, 36] whereas 
those using excitatory protocols (anodal tDCS and tRNS) [22,108], including the present 
study, observed improvements.  This pattern of results is consistent with the homeostasis 
hypothesis which predicts relatively impaired fellow eye function following inhibitory 
stimulation and does not rule out improved fellow eye function following excitatory 
stimulation. This is because excitatory effects may still occur within neuronal populations 
dominated by the fellow eye, just to a lesser extent than those dominated by the amblyopic 
eye. 
 
5.5.2 Successive and cumulative tRNS effects on contrast sensitivity 
A day by day analysis of the contrast sensitivity data revealed that tRNS effects were 
pronounced for both eyes on day 1. However, the within-session tRNS effects waned across 
sessions, becoming non-significant by day 2 for both eyes.  This reduction in within-session 
tRNS effects was accompanied by stable session to session baseline performance indicating 
the absence of a cumulative tRNS effect on contrast sensitivity. The waning of within-session 
effects is consistent with Clavagnier et al’s [40] study of repeated cTBS sessions in 
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amblyopia, however cTBS did induce cumulative effects that improved baseline performance 
across sessions. One possible explanation for the waning of within-session tRNS effects and 
the absence of a cumulative effect on contrast sensitivity relates to stimulation intensity. The 
relationship between tRNS intensity and visual function improvement during stimulation is 
an “inverted U”, whereby stimulation that is weaker or stronger than an optimum level has 
limited effects [28,308]. Lasting changes in cortical excitability induced by prior sessions of 
tRNS might shift the optimal stimulation intensity towards lower levels, causing a waning of 
tRNS effects across sessions if stimulation intensity remains constant. If this is the case, 
tapering stimulation intensity across sessions would be a possible solution.  
 
Another possible explanation for an effect on day 1 and not subsequent days is a placebo 
effect. Although this cannot be completely ruled out, the use of a single masked, between 
subjects design combined with automated collection of outcome measures was intended to 
minimize this source of bias. In addition, participant reported sensations did not differ 
significantly between the two groups suggesting the adequate masking was preserved 
throughout the study.   
 
5.5.3 tRNS effects of crowded and uncrowded visual acuity 
It is not possible to draw strong conclusions relating to the amblyopic eye datasets for 
crowded and uncrowded visual acuity because there were large between-group differences in 
baseline performance that occurred by chance. However, baseline group differences were 
minimal for the fellow eye datasets and the results followed those for contrast sensitivity very 
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closely; significant differences between groups that were characterized by within-session 
improvements early in the experiment and a gradual waning of tRNS effects. This suggests 
that transient tRNS effects occur for a range of visual functions and that long lasting effects 
may occur for uncrowded visual acuity.  
5.6 Study limitations 
The primary limitation of this study is the relatively small sample size. However, there is no 
indication in our data that the lack of long-term effects of visual cortex tRNS on amblyopic 
eye contrast sensitivity is due to insufficient statistical power. We had sufficient power to 
detect an effect of tRNS on day 1 and this effect waned across subsequent sessions. The 
small sample size did preclude the use of stratification for amblyopia subtype and baseline 
clinical characteristics within our randomization procedure and this likely contributed to the 
between group differences in baseline amblyopic eye visual acuity that are present in our 
data.  
5.7 Conclusions 
tRNS can induce short-term contrast sensitivity improvements in adult amblyopic eyes, 
however sessions of tRNS with a fixed set of stimulation parameters do not lead to enhanced 
or long-lasting effects. In agreement with previous non-invasive brain stimulation studies, 
these results demonstrate considerable short-term plasticity within the visual cortex of human 
adults with amblyopia and identify new pathways for future research such as the 
modification of stimulation parameters across sessions to maximize cumulative stimulation 
effects and the exploration of specific rather than random stimulation frequency bands.  
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Chapter 6: General Discussion 
This work investigated tES innovative treatment modality for adults with amblyopia. In 
particular, the overall objective of this work was to assess whether tES can be used as a 
potential treatment option for amblyopia in adult humans. Firstly, we conducted a pilot study 
to identify an effective tES protocol for modulating visual function in healthy adults by 
comparing anodal-tDCS and full spectrum tRNS with sham stimulation. The rationale of our 
pilot study was based on comparative studies that demonstrated tRNS induced greater  
cortical excitability changes than other tES modalities[97,261,262]. However, this pilot study 
did not find significant effects on contrast sensitivity for either tES protocol among healthy 
adults. This may be due to the small sample size, inter and intra-individual differences, the 
stimulation parameters employed or the fact that an optimal contrast sensitivity threshold had 
already been reached within healthy subjects. With regards to sample size, our pilot study 
involved a between subjects design with 6 subjects per group. This sample may not have 
provided sufficient statistical power to detect any significant effects of tDCS or tRNS on 
visual function. While our study recruited limited subjects, it is consistent with a prior study 
by Antal et al.[7] that recruited a slightly larger number of subjects (sample size, n = 15) but 
reported that anodal tDCS did not reveal significant effects on contrast sensitivity in healthy 
adults. Similarly, Brükner et al.[356] found no significant effect of tDCS on phosphene 
perception in healthy adults (sample size, n = 32). Therefore, although it is possible that the 
small sample size may have led to a type II error, compared with similar prior studies in 
healthy adults, the small sample size may not have been the only contributing factor to the 
null effect of tES in healthy subjects. In fact, inter and intra-individual variability in subjects 
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may play an important role in detecting reliable effects of tES protocols. Inter-individual 
variability has been studied by varying stimulation parameters (current intensity, stimulus 
duration, electrode size, positions and polarity). Nitsche and Paulus[88] reported that 
increased tDCS duration and amplitude led to larger and longer lasting effects on cortical 
excitability. However, recent studies have indicated a more complex relationship between the 
duration and intensity of stimulation and changes in cortical excitability. For example, a non-
linear relationship between current intensity and the stimulation efficacy of tES has been 
reported whereby changes in stimulation intensity and stimulation modality (Paired 
Associative Stimulation (PAS25), Anodal transcranial DC stimulation (A-tDCS) and intermittent 
theta burst stimulation (iTBS)) did not alter the effect of stimulation on MEP amplitude or short 
intracortical inhibition (SICI)[247]. Specific intra-individual factors such as gender, age, 
gene phenotype and hormonal levels can also affect the extent of neuroplasticity 
enhancement induced by NIBS[246,248,357–361]. Alternatively, healthy participants may 
already have optimal contrast sensitivity for the stimuli we used, hence, tES could not induce 
an effect beyond the already existing maximum contrast sensitivity threshold within the 
primary visual cortex. For instance, studies in adults with amblyopia have reported 
significant effects of tDCS or tRNS in inducing neuroplastic changes revealed in measurable 
visual function changes[89,108,264]. Although different stimuli were used, these results 
support the idea that tES protocols can elicit significant contrast sensitivity improvements in 





Experiment II involved an objective assessment of tRNS effects on visual cortex excitability. 
We chose tRNS as the stimulation protocol for Experiment II because previous tES protocol 
comparative studies had reported greater efficacy of tRNS effects compared to tDCS and 
tACS [97,261,262].  
 
We investigated the effects of transcranial random noise stimulation on primary visual cortex 
excitability in healthy adults using EEG. The aim of the study was to test the hypothesis that 
active visual cortex tRNS in human adults would induce an acute increase in visual cortex 
excitability as evidenced by increased VEP amplitude. This was the first time the effects of 
tRNS of the visual cortex had been measured objectively using modulation of VEP 
amplitude. Previous studies have used changes in VEP[9,22,90,281,362], auditory evoked 
potential (AEP)[363], MEP[88,364–366] and somatosensory evoked potential (SEP)[367] 
amplitudes to investigate the effect of tDCS on cortical excitability changes. tDCS is a 
polarity-dependent tES modality in which anodal stimulation increases cortical excitability 
whereas cathodal stimulation decreases cortical excitability. However, previous studies 
reported opposite effects of tDCS on cortical excitability measured using evoked potentials in 
different regions of the brain. For instance, studies using MEPs reported that effect of anodal-
tDCS depressed cortical excitability[365], but in contrast effects of anodal-tDCS 
increased[364] cortical excitability, in human primary motor cortex. Also, studies using SEPs 
and AEPs reported similar trend of increased cortical excitability following anodal-tDCS 
cortex[363]. In the visual cortex, Antal et al.[9,362] reported contrasting polarizing effects of 
anodal and cathodal-tDCS for N70 and P100 VEP components, whereby cathodal stimulation 
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decreased the amplitude of the N70 component whereas anodal stimulation increased the 
amplitude of the N70 component. Contrarily, the P100 waveform component increased in 
amplitude with cathodal stimulation whilst anodal stimulation had no effect [9]. In order to 
address the conflicting findings reported from previous studies that used tDCS, it was 
essential to use a non-polarity dependent form of tES, in this case tRNS, to investigate NIBS 
effects on visual cortex excitability.  
Our results revealed that visual cortex tRNS induced visual cortex excitability changes in 
healthy human adults. In particular, we found significant a VEP increase for lateral 
electrodes, however, other electrodes showed non-significant increase for active tRNS 
whereas sham tRNS resulted in VEP amplitude decreases post stimulation. The relative 
decrease in VEP amplitude post tRNS for the sham group could have been due to habituation 
and/or fatigue effects [181,327]. VEP habituation in control subjects occurs as a result of 
repeated checkerboard visual stimulation [313,328–330]. Specifically, when control subjects 
viewed pattern reversing checkerboards repeatedly for 15 mins there was a gradual decrease 
in VEP amplitudes[313]. We observed habituation of the VEP amplitude in the sham tRNS 
condition and habituation probably caused an underestimation of the VEP increase induced 
by active tRNS for both right and left eye conditions. Also, our findings of significant VEP 
increase at a lateral electrode was expected due to the phenomenon of paradoxical 
laterization of hemi-field pattern reversal VEPs as reported earlier by Barret et al.[311], 
whereby higher amplitude visually evoked responses occur at the occipital electrodes placed 
over the hemisphere ipsilateral to the pattern reversal stimulus. Paradoxical localization 
occurs because the electric fields underlying of pattern-reversal VEPs are primarily radially 
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oriented to the generator region which includes the medial surface of the occipital cortex. 
Thus, electrodes placed over the contralateral scalp are more closely aligned with the axis of 
this generator region and therefore recording minimal evoked responses [311,312,334]. Our 
findings are consistent with previous studies [9,22,90,281,362] that used VEPs to investigate 
the effects of visual cortex transcranial direct current stimulation. Hence, our study supported 
the hypothesis that tRNS can induce neuroplastic changes in excitability within the occipital 
cortex of healthy adults.   
 
Lastly, building on our VEP findings, we tested the hypothesis that five daily sessions of 
visual cortex tRNS would lead to improved amblyopic eye contrast sensitivity, crowded and 
uncrowded amblyopic eye visual acuity in adult patients. Our aim was to replicate findings 
from other studies that demonstrated acute effects of single session visual cortex tDCS on 
modulation of contrast sensitivity in amblyopic eyes[21,22] and expand on these earlier 
findings to assess the possibility of long lasting effects with multiple stimulation sessions. 
Our day 1 session revealed reliable acute effects whereby tRNS improved contrast sensitivity 
and visual acuity in both amblyopic and fellow eyes. Studies from animal and humans 
showed that an improvement in visual function in amblyopia is associated with an 
enhancement in visual cortex neuroplasticity[10,62,368]. In agreement with previous non-
invasive brain stimulation studies[21,22], these results demonstrate considerable short-term 
plasticity within the visual cortex of human adults with amblyopia. Therefore, our day 1 
session findings support the evidence that NIBS can be used as a potential tool to promote 
neuroplasticity in adults with amblyopia. We also aimed to assess the possibility of long-
 
 102 
lasting and sustained effects of tRNS on visual function in the amblyopic eye following 
repeated sessions. Our findings showed that tRNS did not induce sustained or long-lasting 
effects on visual function improvements in adult with amblyopia following repeated sessions 
of tRNS. This may be due a number of reasons including the choice of stimulation intensity, 
heterogenicity of amblyopic patients and type of stimuli used. Van der Groen et al.[28] and 
Pavan et al.[308] showed limited effects induced by stimulation intensity that is weaker or 
stronger than an optimal stimulation level. We applied the stimulation intensity to the visual 
cortex across each day which might have shifted the optimal stimulation intensity towards 
lower levels, causing a waning of tRNS effects across sessions. The possible option to avoid 
limited effects could have been tapering stimulation intensity across daily sessions.  
Also, we recruited a heterogeneous sample of participants with amblyopia including different 
types of amblyopia which may have contributed to unreliable effects of tRNS across each 
day. Recruitment of patients was challenging and therefore a homogenous sample was not 
possible. Different forms of visual functions in amblyopia are affected differently by the type 
of amblyopia[42,369]. For instance, strabismic amblyopia greatly affects binocular vision, 
specifically stereoacuity, but less affects contrast sensitivity and monocular spatial resolution, 
whereas anisometropic amblyopia greatly affects fixational stability and contrast sensitivity 
but less affects binocular vision, in particular stereoacuity and binocular motion 
sensitivity[54,227,342,369]. These differential deficits may result from differential effects of 
strabismic and anisometropic amblyopia at the lateral geniculate nucleus (LGN), whereby 
parvocellular and magnocellular pathways are affected differently. The parvocellular 
pathway is mainly responsible for processing low contrast, high spatial frequency and low 
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temporal frequency stimuli, and vice versa for magnocellular pathway[370]. Therefore, 
effects of amblyopia on LGN, for example the parvocellular pathway, result in reduced 
ability to process luminance contrast sensitivity for stimuli of high spatial frequencies and 
low temporal frequencies. 
 
We used Landolt-C optotype stimuli to assess the effects of tRNS. Our choice of stimuli may 
have affected the outcome of the long-lasting effects across daily sessions. Previous studies 
have used grating stimuli or gabor patch stimuli as the outcome measure to assess NIBS 
effects. Studies that used grating stimuli tested the subjects with either low or high spatial frequency. 
However, gabor patches or Landolt C optotype are composed of a mixture of low to high 
spatial frequencies[351,371], capable of detecting different levels of contrast sensitivity 
deficits in amblyopia. We selected Landolt-C stimuli in all the experiments because it is used 
as a clinical outcome measure in the optometric clinic. Therefore, we reasoned that the use of 
these stimuli would allow us to translate tES protocols from research to clinical settings in 
the longer term.  
 
We have demonstrated the tRNS can induce short-term visual function and VEP 
improvements in adults with amblyopia and healthy adults. However, repeated sessions of 
tRNS with a fixed set of stimulation parameters, a heterogeneous amblyopia group and a 
relatively small sample size do not lead to enhanced or long-lasting effects. In agreement 
with previous non-invasive brain stimulation studies, these results reveal substantial acute 
neuroplasticity within the visual cortex of human adults with amblyopia.  
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This work has identified a number of limitations that may have hindered the induction of 
significant long-lasting effects of visual cortex tRNS across several days. These limitations 
include, but not limited to, a fixed stimulation protocol, heterogeneous amblyopia subjects, 
sample size, stimulation of primary visual cortex and task stimulus. Future research should 
employ alternative NIBS protocols, perhaps with varying stimulation intensities and duration, 
to assess long-lasting or sustained effects. Also, we suggest that future studies should 
incorporate the combination of NIBS protocols with perceptual or dichoptic training. To 
reduce inter-individual variability, recruiting homogeneous amblyopia subjects especially 
focusing on recruiting subjects with same type of amblyopia, similar magnitude of visual 
function deficits and subjects who had received similar prior treatment such as patching, may 
contribute to assessing long-lasting NIBS effects. Recruitment of adults with amblyopia is a 
major challenge, however, we suggest the future studies should pay attention to sample size. 
A larger sample in a randomized controlled clinical trial would provide more statistical 
power to avoid a type II error. Lastly, our EEG study showed that visual cortex tRNS 
resulted in significant aftereffects on cortical lateral electrodes, not at the locations with the 
largest amplitudes. Therefore, we suggest that future research should evaluate the combined 
impact of NIBS across channels using source localization techniques to increase power. As 
amblyopia affects multiple levels of visual processing, the location of the NIBS stimulation 
could be systematically altered to explore stimulation of not only to the primary but also to 




EEG could be used as a short- and long-term outcome measure in future studies with 
amblyopic participants. VEPs from amblyopic eyes are markedly diminished and delayed 
and they improve in line with improvements in visual function with treatment in children. 
Thus, any normalization of VEPs induced by NIBS is likely to reflect an impact on cortical 
plasticity as well as visual function in the participants with amblyopic. A well-controlled 
study design that incorporated our suggestions may elicit greater and reliable long-lasting or 
sustained neuroplastic effects within the visual cortex of adults with amblyopia.    
 
6.1 Strengths and Limitations  
This work investigated the efficacy of NIBS as a treatment regimen for adults with 
amblyopia. We showed that visual cortex tRNS induced short-term neuroplastic effects 
within the visual cortex as evident through enhancement of visual function in amblyopia and 
increased occipital VEP amplitude in healthy controls. The main limitation of this work was 
the relatively small sample size in each study. Recruiting for non-invasive brain stimulation 
studies is a major challenge and small sample sizes are prevalent in the literature. In the 
future, larger scale, multi-site studies will be required to increase statistical power and assess 
clinical efficacy. Future work may also involve different stimulation parameters (frequency 
range, current intensity, stimulation duration etc.) and/or combination of brain stimulation 
and perceptual learning techniques to enhance treatment effects. 
   
 
 106 
6.2 Conclusion and future Directions  
It is important investigate the effects of non-invasive brain stimulation on the visual cortex to 
understand the mechanisms that underly the modulation of cortical neurons and to enhance 
visual function in amblyopia.  Our findings buttress the existing reports on the efficacy of 
NIBS in modulating visual cortex neuroplasticity in amblyopia. In agreement with previous 
non-invasive brain stimulation studies, our results demonstrate considerable short-term 
plasticity within the visual cortex of human adults with amblyopia. Future research should 
incorporate the modification of stimulation parameters, session frequencies and combinations 
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Appendix A: Supplementary figures of averaged waveforms generated when 
the pattern reversal VEP stimulus was presented to the cortical hemisphere 
that received tRNS for the right eye viewing condition. 
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